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Abstract
Background: Individuals with head and neck cancer (HNCa) are at an increased risk of
malnutrition. Therefore, self-administered nutrition screens which attempt to
address their nutritional concerns may yield benefits for treatment outcomes and
quality of life (QOL).
Methods: 34 participants (26 men, 8 women) completed one demographic and two
QOL surveys, two nutrition self-screening tools, a nutrition assessment and an easeof-use questionnaire. Results of the screens were compared to those of the
assessment, and relationships between QOL, nutrition status, and demographics
were examined.
Results: 32.3% of participants were identified as nutritionally compromised. The
sensitivity and specificity for the PG-SGA SF and Pt-Global Application were found to
be 81.8% and 100%, and 63.6% and 100%, respectively. Additionally, alterations in
nutrition status were found to influence QOL.
Conclusions: Data suggest that self-administered nutrition screens may be a viable
option which enable proactive identification of nutritional concerns associated with
HNCa.
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CHAPTER 1: INTRODUCTION AND REVIEW OF LITERATURE
Overview
Current statistics regarding the prevalence of cancer indicate that it is one of the
leading causes of morbidity and mortality in the world (Ferlay et al., 2015). In a review
performed by Ferlay et al. (2015) it was estimated that approximately 14.1 million
individuals were diagnosed with cancer in 2012 and 8.2 million deaths resulted from the
disease. While these numbers are staggering, Ferlay et al. (2015) projects the cancer
incidence rate to reach above 20 million annually by year 2025. However, one positive
trend which has been observed in recent years is that cancer survivorship rates are also
increasing due to improvements in diagnostic tools and treatment effectiveness (Arends
et al., 2016; Maruvka, Tang & Michor, 2014). Though the cancer may not be completely
cured, it is slowly being converted into a chronic condition. Thus, quality of life (QOL)
issues are becoming increasingly relevant for those diagnosed with and treated for
cancer as these higher incidence and survivorship rates mean more individuals are going
to be facing these types of challenges (Payakachat, Ounpraseuth & Suen, 2013).
QOL is a multidimensional construct which has been defined by the World Health
Organization (WHO) as a state of “…complete physical, mental and social well-being and
not merely the absence of disease.” How Individuals with cancer feel physically and
mentally, their functionality, as well as the disease and treatment related side-effects all
have the potential to influence QOL. It is well documented that individuals with cancer
generally experience a relatively low QOL due to the many challenges they face during
treatment and recovery (List et al., 1996; List et al., 1997; Payakachat et al., 2013). Of
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the multitude of factors which must be considered while treating individuals with
cancer, maintenance of their nutrition status is a particularly important concern. Though
malnutrition-related issues in oncology have been reported in clinical medicine
throughout the 19th century, it was not until Charles Butterworth Jr’s report of
malnutrition in hospitalized patients in 1974 and Seltzer’s description of nutrition
screening in 1979 that nutrition associated with cancer began to receive significant
attention (Butterworth, 1974; Seltzer et al., 1979). However, malnutrition in hospitalized
settings continues to exist today at alarming rates (Barker, Gout & Crowe, 2011; Giner,
Laviano, Meguid & Gleason, 1996). This was a topic central to a recent systematic review
of literature regarding the nutritional status of individuals with cancer performed by Lis,
Gupta, Lammersfeld, Markman and Vashi (2012) which found that of the 26 articles
which met their inclusion criteria, 24 of them concluded that better nutrition status was
associated with better QOL. However, malnutrition remains an under-recognized clinical
issue in many hospitalized and outpatient populations, including those with cancer.
Considering the consequences malnourishment can have on treated individuals as well
as the costs required to address nutrition related concerns once they have progressed to
later stages, it too regularly goes undiagnosed and untreated (Barker et al., 2011;
Tappenden et al., 2013).
Combining common definitions due to the lack of universal agreement,
malnutrition has been outlined as a subacute or chronic state of nutritional imbalance
(deficiency or excess), resulting from lack of nutrient intake or impaired nutrient
metabolism and inflammatory activity, which causes adverse effects on the body,
2

functioning, and clinical outcome (Lochs, Allison, Meier, et al., 2006; Soeters et al., 2008;
Teitelbaum et al., 2005). The European Society for Clinical Nutrition and Metabolism
(ESPEN) has further outlined nutritional risk as being the situation where the outcome of
a disease or treatment has the potential to be influenced by the nutritional and
metabolic status of the afflicted individual (Kondrup et al., 2003). Individuals diagnosed
with cancer are particularly susceptible to experiencing malnutrition and various dietrelated problems as a result of the malignant disease, its treatment and the commonly
experienced side-effects each of these produce (Gupta, Vashi, Lammersfeld, & Braun,
2011; Lee, Shin, Bae & Lim, 2016; Takenaka et al., 2014).
The approximate incidence of malnutrition in the cancer population varies
between 40-80% (Baldwin & Weekes, 2011; Isenring, Bauer & Capra, 2003) and
prevalence varies between 50-80% (Tong, Isenring & Yates, 2009) depending on factors
such as cancer type, tumour stage, location, treatment modality and identification
method (Baldwin & Weekes, 2011; Lis et al., 2012). These numbers take on increased
importance when one notes that upwards of 20% of individuals with cancer succumb to
the associated malnutrition itself, as opposed to the malignant disease (Ambrus,
Ambrus, Mink & Picken, 1975; Ottery, 1996; Wu et al., 2009). These statistics partially
explain why many individuals with cancer make changes to their eating habits in
attempts to maintain their health (Maskarinec, Murphy, Shumay & Kakai, 2001).
Minimum energy and protein intake levels for individuals diagnosed with cancer have
been outlined by both ESPEN and The American Society on Parenteral and Enteral
Nutrition (ASPEN) as being 30 to 35 cal/kg and 1.2 to 2.0 grams of protein/kg body
3

weight respectively; however, even when these requirements are met, weight loss and
malnutrition can still occur (Arends et al., 2006). Possibly a better approach presented
by Arends et al. (2016) is determining the total energy expenditure of the individual by
calculating their resting and physical activity energy expenditure levels and then
calculating intake requirements from these results. However, this would likely be time
consuming and depend on accuracy of the data collected, calling the practicability and
reliability into question. Thus, reliable, effective, and practical nutrition services are still
being searched for in busy clinical settings. Further, Lee et al. (2016) reported in a study
that 90% of breast and gynecologic cancer survivors called for these nutrition services in
order to address their nutrition-related concerns, emphasizing their importance.
Nutritional management is, therefore, an essential component of cancer care. This may
be particularly true for those diagnosed with a head and neck cancer (HNCa) due to the
nutrition compromising tendencies of tumours in these locations and the common
associated treatments.

HNCa and Compromised Nutrition Status
HNCa comprises malignancies occurring in the upper digestive track such as the
oral cavity, oropharynx, hypopharynx and larynx (Langius et al., 2013b). Representing
approximately 4-5% of newly diagnosed cancers every year (Symonds, Deehan,
Meredith, & Mills, 2012), these types of cancers are the sixth most common worldwide
with the eighth highest mortality rate (Ferlay et al., 2015; Ganzer, Rothpletz-Puglia,
Byham-Gray, Murphy, & Touger-Decker, 2015; Jemal et al., 2011). The annual global
incidence of HNCa is more than 550,000 and results in approximately 300,000 deaths
4

each year (Jemal et al., 2011). The majority of HNCa cases are squamous cell carcinomas,
however, individuals may still suffer from locoregionally advanced states of the disease
(Jemal et al., 2008) and traditional treatments often result in various and significant
functional and psychosocial impairments (List et al., 1997). As such, individuals with
HNCa face many challenges and their QOL has been shown to deteriorate due to factors
such as age, socio-economics, tumor location, treatment modality, treatment-related
toxicity, and other disease specific symptoms (Languis et al., 2013; Penner, 2009; Reeve
et al., 2016; Terrell et al., 2004; Wells et al., 2016). This is very important as health
related QOL has been widely associated with the survival and mortality rates of
individuals with HNCa (Farnebo, Malila, Mäkitie & Laurell, 2016; Karvonen-Gutierrez et
al., 2008; Osthus, Aarstad, Aarstad & Olofsson, 2011; van Nieuwenhuizen, Buffart, Brug,
Leemans & Verdonck-de Leeuw, 2015). To address these threats to QOL, individuals with
HNCa require a variety of supportive care services (Chen et al., 2009; Oskam et al.,
2013). As poor nutrition status has been associated with worse QOL in those with HNCa
(Barrios, Tsakos, García-Medina, Martínez-Lara & Bravo, 2014) it is crucial that their
nutrition-related concerns are addressed.
As a general observation, individuals with HNCa are among the most frequently
confronted with nutritional and diet-related issues of all cancer subgroups (Chasen &
Bhargava, 2009; Lees, 1999; Maskarinec et al., 2001). This is because many anatomical
structures associated with normal nutrient intake have the potential to be impacted by
the tumour and its treatment (Maskarinec et al., 2001). Though incidence rates vary
throughout the literature it has been reported that malnutrition may be present in up to
5

as much as 35-80% of the HNCa population again depending on tumour location,
treatment modality and method of identification (Gupta et al., 2011; Lees, 1999;
Takenaka et al., 2014). Additionally, eating problems such as dysphagia (difficulty
swallowing), odynophagia (painful swallowing), xerostomia (salivary gland dysfunction
causing mouth dryness and potentially reduced salivary flow) and mucositis (painful
inflammation and ulceration of the mucous membranes lining the digestive tract) are
common issues before, during and following cancer therapy (Larsson, Hedelin,
Johansson & Athlin, 2005; Nourissat et al., 2012; Ottosson, Zackrisson, Kjellén, Nilsson &
Laurell, 2013). Such side-effects of the tumour and its treatment can considerably
diminish nutrient intake and make maintaining adequate nutrition and hydration
difficult, subsequently increasing the risk of nutritional deficiency and dehydration
(Grant & Kravits, 2000). This can result in weight losses which may exceed as much as
20% of the individual’s pretreatment bodyweight due to metabolic abnormalities,
increased energy expenditure and reduced dietary intake (Ehrsson, Langius-Eklöf &
Laurell, 2011; Kubrak, Olson & Baracos, 2013). This significant nutritional decline and
weight loss is clinically relevant as it has been shown to reduce the effectiveness of
treatment, impair functionality, reduce QOL, and lower the survival rates of hospitalized
individuals with HNCa (Farhangfar et al., 2014; Kubrak et al., 2013). Thus, when
reflecting on the care and QOL of individuals with HNCa more attention must be
dedicated to considering the impact of nutritional status. These concerns are likely also
prominent among the outpatient population.
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Currently, much of the literature related to nutrition in those with HNCa has
focused on the hospitalized patient population. Thus, the experience of outpatients with
HNCa has not been well explored. This is concerning as it is likely that they too may
experience similar nutritional challenges to those of hospitalized individuals. However,
how different treatment modalities influence the nutritional experience of these
individuals, as well as examination into the challenges they commonly experience are
questions which have not received significant attention. If the nutritional concerns of an
outpatient population are found to be similar to that of their hospitalized counterparts,
they could be suffering similar impacts to their QOL. Further attention dedicated into
exploration of the unique challenges the outpatient population faces in regard to their
nutritional status and how this influences their health and QOL must be pursued. Thus,
the primary focus of this research was to attempt to identify the nutritional status of
outpatients with HNCa through implementation of two self-administered nutrition
screening tools. Specific questions we address in this study include an assessment of the
reliability of self-administered nutrition screens, examination of the common nutrition
impact symptoms in the outpatient HNCa population, and how these nutritional
concerns may influence perceived QOL.
Lack of a Universal Definition of Malnutrition and Screening Method
Nutritional deficiencies can have a vast array of consequences for individuals
with HNCa such as increased infections rates, treatment disruptions and increases in
morbidity and mortality (Capuano et al., 2008). To overcome these concerns nutritional
supports may be necessary to meet daily nutritional requirements (Dawson, Taylor &
7

Bragg, 2015). Various efforts have attempted to standardize these nutrition support
guidelines. Current examples include a Wiki platform that allowed professionals
worldwide to input their nutritional recommendations for individuals with HNCa (Brown
et al., 2013), the ‘ESPEN guidelines on nutrition in cancer patients’ (Arends et al., 2016),
and the American Dietetic Association medical nutrition therapy protocol (“Medical
nutrition therapy protocols”, 1999). However, despite these various efforts, their effects
in clinical settings are often impeded due to frequent lack of interest in nutritional
aspects of cancer care (Arends et al., 2016) as well as the variability in both the content
and implementation of these guidelines. This lack of clarity makes it difficult to identify
the most effective methods of nutrition support and intervention for the HNCa
population (Nugent, Lewis, & O’Sullivan, 2011).
Despite the lack of guidelines, nutritional concerns can still be addressed through
adoption of proactive interventions which seek to avert malnutrition-related
consequences by preventing nutritional declines (Cushen, Power, & Ryan, 2015).
Currently, screening and assessment tools are used to assess nutritional status in clinical
settings, including oncology. However, these assessments are complicated by that fact
that agreement has yet to be achieved on a universally accepted definition of
malnutrition in the HNCa population (Meijers, van Bokhorst-de van der Schueren,
Schols, Soeters & Halfens, 2010; Soeters et al., 2008).
Though experts tend to agree that energy and protein deficiency, as well as
decreases in fat-free mass are important aspects of the definition, there is less
consensus regarding the importance of other elements such as the role of functional
8

status and inflammation (Dechaphunkul et al., 2013; Meijers et al., 2010). Even the
elements which are currently accepted as being important are debated among experts
regarding the cut-off points at which these factors become significant indicators of
malnutrition (Meijers et al., 2010). This has complicated the operationalization and
identification of malnutrition beyond the simple symptoms of involuntary weight loss,
reduced body mass index (BMI) and nutritional intake (Meijers et al., 2010). Due to this
lack of agreement, current definitions of what health care professionals consider to
constitute a diagnosis of malnutrition has varied. ESPEN believes that “malnutrition is a
state of nutrition in which a deficiency, excess, or imbalance of energy, protein and
other nutrients causes measurable adverse effects on tissue/body form (body shape,
size, and composition) and function, and clinical outcome” (Lochs, Allison, Meier, et al.,
2006, p. 182). ASPEN defined malnutrition as “any disorder of nutrition status including
disorders resulting from a deficiency of nutrient intake, impaired nutrient metabolism,
or overnutrition” (Teitelbaum et al., 2005, p. 282). In the literature, various other
definitions have been used, the most common being unintentional weight loss of >10%
in the last 6 months or >5% in the last 3 months (Gorenc, Kozjek, & Strojan, 2015). In
addition to these definitions, the National Cancer Institute’s Common Toxicity Criteria
has outlined different degrees of weight loss; less than <5% as Grade 0; 5%-10% as
Grade 1; 10-20% as Grade 2; and >20% as Grade 3 (National Cancer Institute, 2005). The
inconsistencies and lack of agreement among the definitions of weight loss and
malnutrition is concerning. Only once the pathophysiology of malnutrition is firmly
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agreed upon can there be generation of an appropriate and accurate definition and
measurement tool to assess and diagnose the condition (Soeters et al., 2008).
The current lack of a universal definition of malnutrition makes the formation
and validation of tools which can accurately identify and assess the condition difficult.
Until a universal classification of weight loss and malnutrition is identified, there will be
no common ground from which nutrition screens, assessments and interventions can be
structured. As this is presently the case, the criteria and methods used to screen for the
risk of malnutrition in the HNCa population has varied (Thoresen et al., 2013). This has
resulted in inconsistencies regarding the classification of individuals based on their
nutritional status (Thoresen et al., 2013) giving rise to the concern of misclassification
(Elia, Zellipour & Stratton, 2005; Platek, Hertroijs, Nicholson & Parekh, 2015). As a result,
individuals who require nutritional interventions may be missed and those who receive
them may be well-nourished. This has consequences for both the individual and the
healthcare system, decreasing the efficiency and effectiveness of clinical nutrition
services (Platek et al., 2015). When this lack of guidelines is considered along with other
current barriers to the implementation of nutrition screens, it is not surprising that
compliance has been low. Competing duties of healthcare professionals, the lack of
resources, time restrictions, as well as many other challenges have restricted regular
nutrition screening (Elia et al., 2005). A reliable nutrition screening tool for the HNCa
population which could overcome such barriers would be extremely beneficial. Such a
measure would reduce the potential of misclassification while also enabling early
identification and intervention, improving treatment outcomes and resource allocation.
10

However, for a nutritional screening tool to be effective for individuals with HNCa, it first
must accurately assess, either directly or indirectly the main causes of malnutrition
within this population. This is by no means a simple task as the malnutrition experienced
by individuals diagnosed with HNCa is often a complicated multifactorial problem.
Causes of Malnutrition in HNCa Populations
Unintentional weight loss leading to malnutrition in individuals diagnosed with
HNCa is a serious and complicated issue. Often, the malnutrition experienced is due to a
combination of the cancer and its treatment, the resulting side effects and metabolic
alterations each of these produce, as well as other personal factors (Languis et al.,
2013a; Langius et al., 2016). These factors combine to increase the difficulty of nutrient
consumption for individuals with HNCa and may subsequently result in abnormal
metabolic activity such as elevated energy expenditure leading to energy imbalances
(Arends et al., 2006; Dechaphunkul et al., 2013). The metabolic alterations and dietary
issues can have synergistic effects on nutrition, increasing nutritional decline. The
multifactorial and complex nature of the condition makes addressing the nutritional
deficiency of individuals with HNCa difficult. One factor impairing the nutrition status of
individuals with HNCa is the tumour itself due both to its anatomical location and the
potential symptoms it can produce.
Tumour Related Causes of Malnutrition in HNCa
Tumours of the head and neck can impair oral intake in many ways. Nutrient
intake impairment often increases with later tumour stages and tumours located in
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oropharynx/oral cavity leading to greater degrees of weight loss (Bozzetti, 2009; Ehrsson
et al., 2011; Lønbro, Petersen, Andersen & Johansen, 2016; Ravasco, Monteiro-Grillo,
Vidal & Camilo, 2003). The tumour’s anatomical location can generate nutrition impact
symptoms such as nausea and vomiting, increasing malnutrition risk by impairing
nutrient retention and making achievement of adequate hydration and nutrition difficult
(Capuano et al., 2010; Grant & Kravits, 2000; Santarpia, Contaldo & Pasanisi, 2011). The
tumour may also mechanically impede oral intake through symptoms such as dysphagia
and odynophagia which impair swallowing function (Alshadwi et al., 2013; JagerWittenaar et al., 2011; Santarpia et al., 2011;).
Dysphagia is often considered one of the most common and disabling nutritionrelated complications resulting from HNCa and its therapy (Chasen & Bhargava, 2009;
Kubrak et al., 2010). This is particularly true for those with tumours of the oral cavity or
oropharynx (List et al., 1997; Rinkel et al., 2015). Often the severity of the dysphagia
experienced is dependent on the size and anatomical location of the lesion, the surgical
resection and reconstruction, and comorbidities (Chasen & Bhargava, 2009). Severe
dysphagia can make consumption of various food types difficult, which may significantly
impact nutrition. Furthermore, as swallowing function declines muscles associated with
proper swallowing can lose mass which further decreases nutrient intake and increases
weight loss (Lis et al., 2012). As such, swallowing problems are a particularly important
nutritional concern for individuals with HNCa.
Continuous or occasional pain caused by tumours during oral consumption is also
a common tumour-related problem which may alter or limit oral intake (Larsson et al.,
12

2005; Santarpia et al., 2011). Pain has been identified as an important variable during
treatment as it has been associated with increased functional impairments, depression,
decreased QOL, psychological distress and aggregate symptom burden (List et al., 1997).
These nutritional impacts which result from the tumour may result in the
development of tumour-induced metabolic dysfunction (Fearon, Voss, Hustead & Cancer
Cachexia Study Group, 2006; Santarpia et al., 2011), leading to symptoms such as
elevated energy expenditure, skeletal muscle catabolism (the breakdown of muscle
mass to produce energy) and tumour-induced anorexia (Fearon et al., 2006; Mueller,
Compher & Ellen, 2011). All of these factors may collectively increase weight loss and
the corresponding risk of malnutrition. Thus, the tumour itself can lead to significant
weight loss for individuals with HNCa which is only exacerbated once treatment begins.
Treatment Related Causes of Malnutrition in HNCa
It is well documented that common treatment modalities for HNCa such as
radiotherapy, chemotherapy, and surgery have the potential for side-effects which
cause weight loss and malnutrition. Antineoplastic treatments, especially when
combined, may increase nutritional demand or cause side-effects which reduce dietary
intake (Ehrsson et al., 2011; Van Cutsem & Arends, 2005). Surgery can lead to anorexia,
pain, disfigurement, asthenia (abnormal physical weakness or lack of energy), anxiety,
depression, xerostomia, and impairments in mastication, swallowing, communication,
and potentially breathing (Doyle & Keith, 2005; List et al., 1996; List et al., 1997; Miller &
Bozeman, 2012; Oskam et al., 2013; Payakachat et al., 2013; Penner, 2009). The sideeffects of surgical interventions can influence the ability and willingness of individuals
13

with HNCa to intake nutrition orally which then can result in nutritional declines (List et
al., 1997; Macqueen & Frost, 1998; Ravasco et al., 2003).
Other treatment methods such as chemotherapy and radiotherapy commonly
involve intensive treatment regimens which are associated with elevated metabolic
rates and increased treatment-related toxicity and complications (Jager-Wittenaar et al.,
2011; Payakachat et al., 2013). The side-effects of these regimens are often the primary
factors limiting the nutrient intake of individuals with HNCa (Macqueen & Frost, 1998)
and commonly result in unintentional weight loss (Dawson et al., 2015). This was
exemplified in a study performed by Langius et al. (2016) which concluded that radiation
to lymph nodes and higher radiation doses to the primary tumour were predictors of
increased side-effects and critical weight loss in individuals with cancer. Additionally, the
treatment field is also an important consideration during HNCa treatment due to its
potential influences on nutrition. It can cause radiation induced mucositis (an
inflammatory response of mucosal epithelial cells) which is associated with pain during
chewing and swallowing, oral bleeding, odynophagia, dysphagia, and mucosal
ulcerations (Hayward & Shea, 2009; Miller & Bozeman, 2012; Santarpia et al., 2011). This
can be further exacerbated by the radio-sensitizing drugs administered during cancer
treatments (Hayward & Shea, 2009). Overall, treatment fields for HNCa can include
organs and structures important for chewing and swallowing which if altered as a sideeffect of treatment can result in temporary or permanent chewing and swallowing
dysfunction which may then influence nutrient intake (Alshadwi et al., 2013; Eisbruch et
al., 2002). This is especially concerning for those individuals with HNCa receiving a
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combination of radiation and chemotherapy, which increases treatment toxicity
(Santarpia et al., 2011).
Increases in treatment toxicity during HNCa treatment has been associated with
xerostomia, stomatitis (inflammation of oral tissue, mucosa, dentition, and
periodontium), anorexia, dysgeusia (alterations in taste), anosmia (loss of smell), trismus
(reduced mobility of the jaw muscles), nausea and vomiting, sore throat, constipation
(Alshadwi et al., 2013; Chasen & Bhargava, 2009; Hayward & Shea, 2009), fibrosis of
tissues (including muscle and connective tissue) and possible neurotrauma causing
dysphagia (Chasen & Bhargava, 2009). These nutritional concerns can have long-lasting
impacts on individuals treated for HNCa (Payakachat et al., 2013). Consequently,
individuals with HNCa are not only at risk of malnutrition prior to and during treatment,
but also throughout the survivorship period.
The importance of treatment-related nutritional concerns is emphasized by that
fact that regardless of the individual nutrition impact symptoms present, increases in
aggregate symptom burden has been shown to further reduce nutrient intake, survival
rates, and QOL (Capuano et al., 2010; Farhangfar et al., 2014; List et al., 1997; Reeve et
al., 2016). Hall, Groome, and Rothwell (2000) concluded that 18% of individuals with
HNCa included in their study died of the increased comorbidity associated with
treatment and that many of these nutritional concerns remained burdensome for up to
7.5 years following treatment. Treatment-related concerns may be particularly
important for individuals with HNCa who are in advanced stages of the disease or
experiencing limited performance status as both of these factors have been associated
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with greater aggregate symptom burden (Farhangfar et al., 2014). Thus, it is critical that
the nutrition-related impacts of treatment be addressed for those with HNCa. If tumour
and treatment characteristics were the only factors which needed to be considered to
implement a nutrition management strategy the solution would be straightforward.
Unfortunately, tumour and treatment characteristics must be considered alongside
other variables and personal factors specific to the individual being treated for HNCa.
Objective Personal Factors Causing Malnutrition in HNCa
For a complete description of what causes malnutrition in individuals with HNCa,
consideration must be given not only to tumour and treatment-related factors, but also
to personal factors. This latter category includes objective factors such as tobacco and
alcohol consumption which suppresses appetite and therefore influence nutrition
(Alshadwi et al., 2013; Hall et al., 2000; Reeve et al., 2016). The risk of malnutrition also
tends to increase as one ages (Roller, Eglseer, Eisenberger & Wirnsberger, 2016; Stratton
& Elia, 2005) due to various factors such as poor appetite and dentition, loss of taste and
smell, gastrointestinal disorders, isolation, poverty, inability to prepare food, confusion,
and dementia (Hickson, 2006). Conversely, it is also possible for younger individuals to
experience increased weight loss based on their higher activity levels and energy
expenditure (Langius et al., 2016) or greater reductions in muscle mass due to functional
declines associated with treatment (Languis et al., 2016). Additionally, it should also be
noted that the selected treatment modality can be influenced by age, resulting in
differing impacts to nutritional status.
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As older individuals are expected to fare worse during treatment there is greater
focus placed on supportive aspects of care (Languis et al., 2016). This supportive focus
can be less present with younger individuals who are expected to better tolerate more
intense treatment regimens (Reeve et al., 2016; VanderWalde, Fleming, Weiss & Chera,
2013). The more intense treatments can have consequences for the QOL and nutrition
status of younger individuals (Reeve et al., 2016; VanderWalde et al., 2013). Overall, it is
imperative that all individuals with HNCa are informed regarding the likely impacts to
their nutrition based on their age. This is especially important seeing as those with
insufficient information tend to experience greater difficulties maintaining weight and
experience more treatment-related side-effects (Gorenc et al., 2015).
Finally, economic factors are often forgotten influencers of nutrition status as
they can also impact treatment progression, nutrient intake, and QOL (Wells et al.,
2016). This is concerning as individuals treated for HNCa have among the highest risk of
experiencing disability and ceasing employment, limiting financial income (Liu, 2008;
Penner, 2009; Taylor et al., 2004). This is a problem as foods high in nutritional value
tend to be more expensive, causing individuals with limited financial resources to opt for
the cheaper and less nutritious options. Additionally, cancer treatments and nutritional
supplements can be expensive (Russell, 2007), which may influence their use if
individuals lack insurance coverage and are unable to pay out-of-pocket. This would
have consequences for nutrition status, disease progression, treatment outcome, and
QOL (Reeve et al., 2016).
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Subjective Personal Factors Causing Malnutrition in HNCa
Individuals with HNCa are also affected by subjective factors which may impair
nutrient intake. For example, nutritional status may be negatively affected as the
individual’s food enjoyment declines (Hayward & Shea, 2009; McQuestion, 2006; Redda
& Allis, 2006). The symptoms and side-effects experienced during HNCa treatment such
as xerostomia, suppressed appetite, swallowing difficulty and many others may result in
increases in the time and effort required to consume food (Gorenc et al., 2015;
McQuestion, 2006). These difficulties can decrease eating-related QOL as well as one’s
motivation to consume food orally as eating becomes less enjoyable and more simply
about survival (Álvarez-Camacho et al., 2016a; Pateman, Ford, Batstone & Farah, 2015).
As nutrition impact symptoms are common among those treated for HNCa, it is
not surprising that food aversion is also a common concern in up to 60% of these
individuals (Chasen & Bhargava, 2009). Meals may become stressful and timeconsuming events due to the extra time devoted to mastication and swallowing;
individuals also may feel uncomfortable or embarrassed by not being able to eat in ways
deemed socially acceptable; for example, they may struggle with keeping their mouths
clean during eating or experience frequent coughing (McQuestion, 2006; Ottosson,
Laurell & Olsson, 2013; Penner, 2009). These difficulties may impair nutritional intake as
well as lead to social isolation, exclusion or disruption of relationships with social
supports, and a hesitance to eat in the presence of others who do not understand their
situation (Álvarez-Camacho et al., 2016b; Chasen & Bhargava, 2009; List et al., 1996; Ma,
Poulin, Feldstain & Chasen, 2013; Penner, 2009). This potential impact on one’s social
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activities results in an increased risk of depression for individuals with HNCa (List et al.,
1996; Van Liew et al., 2017). This emphasizes the impact the emotional burden may
have on the individual as well as their nutritional status.
The emotional stress and existential crisis the individual may experience during a
cancer diagnosis and treatment may reduce nutrient intake, causing nutritional decline
(Capra, Ferguson & Ried, 2001; Larsson et al., 2005). Thus, the psychological, social, and
emotional domains of food consumption are also afflicted (Ottosson et al., 2013a; Reeve
et al., 2016). This subjective concern may be particularly important for younger
individuals as aggressive treatments are more common, increasing the extent and
severity of potential comorbidities, psychological impacts, and distress experienced
(Dawson et al., 2015; Hoffman, McCarthy & Ng, 2008).
Cancer Cachexia as a Cause of Malnutrition in HNCa
Overall, tumour-, treatment- and personal factors all combine to produce the
levels of malnutrition that individuals with HNCa experience. The anorexia resulting from
these nutrition impact symptoms is a serious and multidimensional nutritional issue
which when combined with the associated metabolic abnormalities can ultimately lead
to cancer cachexia. Cancer cachexia is a metabolic syndrome which combines anorexia,
reduced nutrient absorption, appetite and/or diet alterations, hormone-induced
metabolic changes, weakness, anemia, and edema which is a distinct nutritional
problem from either simple starvation or chronic malnutrition (Arends et al., 2016;
Couch et al., 2015; Miller & Bozeman, 2012; Ravasco et al., 2003; Thomas, 2007;). During
simple starvation and chronic malnutrition metabolic rates tend to adaptively decline
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with reduced energy intake, whereas cachexia is associated with hypermetabolism
(Baracos, 2006).
Cachexia is a complex systemic response to starvation, proinflammatory
cytokines, and hypermetabolic states caused by the underlying malignant disease,
negative energy balance, and skeletal muscle wasting which results from reductions in
nutrient intake (Baracos, 2006; Chasen & Bhargava, 2009; Couch et al., 2015;
Dechaphunkul et al., 2013; Miller & Bozeman, 2012; Thomas, 2007). The potential
metabolic alterations associated with cachexia such as hypermetabolism, insulin
resistance, lipolysis, proteolysis results due to failures in anabolic pathways and
activation of catabolic ones (Baracos, 2006). This leads to decreases in protein synthesis
and depletion of physiologic energy and protein reserves at a rate that is greater than
would be expected based on the food intake rates (Baracos, 2006; Couch et al., 2015).
These metabolic alterations along with symptoms such as decreased appetite, functional
impairments, inflammation reducing body cell mass, and fatigue, can greatly impact the
nutritional status and body composition of the individual and have detrimental effects
on overall performance status and QOL (Barac-Nieto, Spurr, Lotero & Maksud, 1978;
Chasen & Bhargava, 2009; Couch et al., 2015; Gorenc et al., 2015). Perhaps most
importantly and understandably, cachexia has been identified as a condition that is
associated with high mortality rates (Thoresen et al., 2013). Approximately 20% of
individuals who succumb to HNCa do so as a result of functional cardiac impairment that
occurs in response to the wasting of the cardiac muscle associated with cachexia (Couch
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et al., 2015; Prakash et al., 2010; Der-Torossian, Gourin & Couch, 2012; Tisdale, 2002).
Thus, cachexia poses threats to nutrition status, QOL, and survival.
Concerns associated with cancer cachexia are further confounded by the fact
that conventional nutritional support methods such as nutritional supplements and
appetite stimulants are unable to fully reverse the weight loss experienced (Baracos,
2006; Chasen & Bhargava, 2009; Dechaphunkul et al., 2013; Thomas, 2007). This is likely
why cachexia is associated with greater treatment toxicities and reduced treatment
tolerance (Couch et al., 2015). Despite the consequences and morbidity generated by
cancer cachexia, this complex condition is not completely understood.
Overall, the intertwining effects of the tumour, its treatment and personal
factors create a multidimensional nutritional problem for which intervention is
complicated. The fact that so many factors combine to produce the malnutrition
experienced by individuals with HNCa warrants interprofessional collaboration. The
implementation of an accurate and standardized screening tool to identify these causes
of malnutrition could yield significant benefits to both treatment outcomes and QOL. If
nutritional concerns are continually disregarded aspects of cancer care the
consequences to the healthcare system and the individuals it cares for could be severe.
Consequences of Malnutrition in HNCa
The incidence of malnutrition among individuals with HNCa has been estimated
to be between 35-80% and that nearly 20% of individuals with HNCa die as either a
direct result of it or its associated consequences, as opposed to solely the cancer (Gupta
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et al., 2011; Takenaka et al., 2014; Wu et al., 2009). Weight loss of just 5% over six
months is associated with various side-effects and consequences (Ma et al., 2013).
Increased mortality, morbidity, fatigue, impaired QOL, impaired immunity, more
frequent and severe treatment induced toxicities and treatment interruptions, reduced
treatment response rates, and greater hospital readmission rates are all consequences
associated with malnutrition (Capuno et al., 2008; Correia & Waitzberg, 2003; Bozzetti,
2009; Gorenc et al., 2015; Nitenberg & Raynard, 2000). Malnutrition resulting from
HNCa and its treatment has also been associated with higher rates of insomnia, anxiety,
depression, psychological distress and reduced physical, role, social, cognitive and
emotional functioning (Arends et al., 2016; Capuano et al., 2010; Ma et al., 2013; Oskam
et al., 2013; Schmidt, Olson, Kubrak, Parliament & Ghosh, 2013). Approximately 35-40%
of individuals with HNCa experience these types of distressing issues over the course of
their illness and rates increase as nutrition status declines (Ma et al., 2013). Additionally,
5-year survival rates are inversely proportional to weight loss, illustrating how the
effects of malnutrition extend into survivorship (Languis et al., 2013a). These symptoms
and side-effects can contribute to further disease progression and a declining QOL and a
subset may even result in further impairments to nutritional status. These consequences
are concerning given that >50% of individuals in advanced stages of HNCa experience
impaired nutrition and significant involuntary weight loss at diagnosis prior to
commencing treatment (Chasen & Bhargava, 2009; Larsson et al., 2005; van Leeuwen,
Sauerwein, Kuik, Snow, & Quak, 1997;). These numbers increase over the treatment
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period in the absence of nutritional interventions (Chasen & Bhargava, 2009). This can
result in consequences for the treated individual as well as the healthcare system.
Past studies have assessed the impact of malnutrition on the healthcare system
and shown that the average cost of hospitalization is much greater for malnourished
individuals (Nitenberg & Raynard, 2000). These increased costs of malnutrition are
indirectly attributable to longer hospital stays, increased resource use (consultations,
treatments, etc.), higher rates of re-admissions, higher infection rates and poor wound
healing (Abizanda, Sinclair, Barcons, Lizán & Rodríguez-Mañas, 2016; Correia &
Waitzberg, 2003; Lim et al., 2012). Groups such as ESPEN and the Alliance to Advance
Patient Nutrition have expressed their belief that addressing clinical nutritional concerns
could reduce costs and improve outcomes and QOL (Kondrup et al., 2003; Tappenden et
al., 2013). Standardized nutrition screening and care could achieve this goal. Thus, the
routine implementation of guidelines and tools to meet this need is warranted as it
would result in benefits not only to the individual, but to the healthcare system as well.
Screening Nutrition Status in HNCa
By definition, screening in medicine is the process of identifying someone at risk
from a given population of individuals who may not have any obvious signs or symptoms
(Cayne & Bolander, 1991). Though the risk of malnutrition is expected to be high for
individuals with HNCa, unless obvious signs are present, it should not be assumed that
they are at risk until it is proven through nutritional screening. Thus, screening for
nutritional risk and the making of appropriate referrals for nutrition assessment are
considered to be fundamental first steps in the nutritional care pathway (Atkins,
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Basualdo-Hammond, Hotson & Dietitians of Canada, 2010). For hospitalized individuals,
nutrition screening should be undertaken immediately following admission and at
regular intervals thereafter, ideally by a nurse in daily contact with them (Arends et al.,
2016; Davies, 2005). Nutrition screens briefly examine characteristics commonly
associated with nutrition problems through a short survey or questionnaire (typically
requiring less than 5 minutes) (Lee, Choi, Son & Lyu, 2013, p. 118; Mueller et al., 2011, p.
16; Zekri et al., 2014). Through screening, those at nutritional risk can be identified to
undergo further detailed nutrition assessments and, if necessary, interventions. The aim
of this process is to prevent nutritional declines and long-term nutritional impacts, as
well as to reduce morbidity and mortality during and following treatment (Arends et al.,
2016; Miller & Bozeman, 2012). Thus, the content, practicability, intended purpose,
reliability, and predictive and content validity are all important considerations when
selecting a screening tool in order to ensure the appropriate individuals are being
identified as nutritionally compromised (Cushen et al., 2015). An efficient screening tool
which addresses these considerations would be beneficial to clinical care.
ASPEN has recommended that healthcare institutions generate and approve
some type of standard nutrition screening process (Ukleja et al., 2010). Additionally, in
the US, the Joint Commission mandates nutrition screening within 24 hours of admission
to an acute care center as it is a “Medicare Condition of Participation” (Joint Commission
International Accreditation Standards for Hospitals, 2013) and, therefore, a requirement
for accreditation or certification of United States healthcare facilities (Centers for
Medicare & Medicaid Services, 2003; Skipper, Ferguson, Thompson, Castellanos, &
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Porcari, 2012). Nutrition screening for individuals with HNCa is in accordance with these
goals and is a promising means through which nutritional concerns could be addressed.
Current Situation of Nutritional Screening Tools
Despite the potential benefits of standardized routine nutrition screening,
compliance to these nutrition evaluations remains low likely due to the lack of interest
in nutrition-related aspects of care (Arends et al., 2016). Despite nutrition screening
practices being mandated, there is debate regarding which tool should be used and who
should be responsible for performing nutrition screens. This lack of agreement has
complicated the establishment of consistent practices. Various screening tools have
been promoted, each of which assesses malnutrition slightly differently. Within
oncology, many of the promoted screens are sophisticated, time-intensive, and require
skilled personnel to complete (Zekri et al., 2014). As well, different subsets of nutrition
screening tools have been recommended, including but not limited to, the Nutritional
Risk Screening 2002 (NRS 2002), Malnutrition Universal Screening Tool (MUST), Mini
Nutritional Assessment (MNA), Nutritional Risk Index (NRI) and Malnutrition Screening
Tool (MST) (Gorenc et al., 2015; Jones, 2002; Kondrup et al., 2003; Lis et al., 2012).
These screening tools have been created to best fit the needs of various healthcare
settings and professionals, and each has its strengths and weaknesses. However, many
of these tools were validated using biased processes or underwent insufficient
evaluations of their effectiveness (Jones, 2002). For example, some tools were validated
using the same rater to complete the nutrition screen and assessment, introducing
potential biases (Ferguson, Capra, Bauer & Banks, 1999; Laporte et al., 2015). Other
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research on nutrition screens has been conducted using trained researchers or
healthcare professionals which potentially inflates results regarding the accuracy of the
screening tool in question (Ferguson et al., 1999; Laporte et al., 2015). Resultantly, the
validity and reliability of these tools is unclear in ‘real-world’ settings where nutrition
screens are often completed by busy staff with limited training (Laporte et al., 2015).
As a result of this lack of standardization in nutrition screening, BMI and body
weight loss are often the primary tools utilized for nutrition screening (DeCicco,
Wunderlich, & Emmolo, 2011). Although effective indicators in some studies, BMI
methods have limitations as alone they often fail to indicate important disease or
therapy-related changes in the individual’s caloric intake and metabolism (DeCicco et al.,
2011; Isenring, Capra & Bauer, 2004). Additionally, the cut-off points for BMI are often
arbitrary and based on young, healthy adults (Davies, 2005) which may not be
appropriate for individuals with cancer. Furthermore, it is possible for individuals with
BMIs of <18.5 to remain well-nourished while malnutrition may be overlooked in those
classified as normal or overweight (Davies, 2005; Gupta et al., 2011; Isenring, Cross,
Daniels, Kellett & Koczwara, 2006; Ottosson et al., 2013b; Soeters et al., 2008). Higher
levels of body fat may mask the loss of lean body mass, leading to unidentified
malnutrition (Bauer, Capra & Ferguson, 2002; Isenring et al., 2004). Additionally, studies
have shown that a BMI of >25 is associated with increases in weight loss experienced by
individuals treated for HNCa (Lønbro et al., 2016). Thus, using BMI as the sole indicator
of nutrition status is not recommended and additional nutritional screening methods are
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necessary. However, barriers present in both the healthcare system and current
screening tools complicate their routine implementation in clinical settings.
Current Issues Regarding the Implementation of Routine Nutrition Screens
Routine screening for malnutrition has been made mandatory in the UK, US and
parts of Europe. However, compliance has been low or, as previously indicated, simple
measurements such as BMI have been used despite their limitations. Routine nutrition
screening has not been possible due to various challenges such as limited human and
financial resources and time restrictions (Abbott et al., 2014; Santarpia et al., 2011). It is
estimated that these nutrition care practices would result in an additional 0.3-2.0 hours
of professional labour per evaluation (Arends et al., 2016). As clinicians already
experience heavy workloads, provision of these services often fall to other healthcare
team members.
As physicians are unable to regularly provide nutrition services, tasks such as
nutrition screening is generally carried out by nurses (Green & Watson, 2005). Nurses
are arguably the most appropriate members of the healthcare team to screen for poor
nutritional status as they are likely to have more frequent interaction with the
individuals being screened (Molassiotis & Holmes, 2005). However, nurses themselves
have outlined various challenges impeding their ability to implement regular nutrition
screens, such as heavy workloads, their perception that professional judgement is just as
useful as screening tools for identifying malnutrition, inadequate nutrition screening
knowledge and training and a lack of awareness of evidence-based nutrition screening
practices (Raja et al., 2008). This is supported by Martin, van der Schueren, Blauwhoff27

Buskermolen, Baracos and Gramlich (2014) who identified that the lack of clear
guidelines for nutrition screens was the main barrier to their routine implementation.
Without clear guidelines the difficulty of accurately detecting individuals at nutrition risk
in a standardized manner increases.
Further barriers to the implementation of nutrition screens identified by Martin
et al. (2014) included disagreement regarding which tools were most appropriate,
whose responsibility it was to perform the screens, and what proper protocol was
following screening. To date, these concerns have posed major challenges to the regular
completion of nutrition screens in clinical oncology.
The Ideal Nutritional Screening Tool
The ideal nutrition screening tool would be able to proactively identify
individuals at risk of malnutrition with 100% sensitivity and specificity. This is, however,
unlikely an achievable goal. A good screening tool is characterized by both sensitivity
and specificity of at least 80% (Azad, Murphy, Amos & Toppan, 1999; Platek et al., 2015).
Sensitivity enables appropriate detection and referral of malnourished individuals, while
specificity reduces interventions provided to those who are well-nourished and prevents
unnecessary referrals (Shahar & Hussain, 2007). Though both sensitivity and specificity
are important, the need to correctly classify all malnourished individuals (tool sensitivity)
may take precedence (Skipper et al., 2012). ESPEN has further stated that an idealized
screening tool should be simple, able to be standardized, rapid, non-invasive, and costeffective for clinical practice (Kondrup et al., 2003). Additionally, Soeters et al. (2008)
suggested that nutritional assessments which evaluate nutrient balance, body
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composition, inflammatory activity, and functionality would provide an accurate
description of an individual’s nutritional state. Thus, screening tools which incorporate
similar measurements may also prove effective. However, screening tools should avoid
calculations and the need for laboratory data as these measures complicate nutrition
screening (Green & Watson, 2005; Leuenberger, Kurmann & Stanga, 2010). Finally, an
ideal screening tool should be linked to a protocol for action to direct the next steps of
nutrition care to ensure efficient and effective allocation of resources (Leuenberger et
al., 2010). Thus, a simple and efficient tool could enable proactive nutrition screening in
clinical settings and even potentially be self-administered.
In the clinical literature, it does not appear as though any current tools meet all
the criteria of an ideal nutrition screening tool, nor have self-administered nutrition
screening tools been given significant attention. Only minimal work has been done
assessing the application of self-administered nutritional screens in clinical settings. If
proven accurate and effective, such screens could yield unique benefits. Selfadministered nutrition screens can be rapid, simple, reliable, and feasible for clinical
settings and could facilitate the regular completion of screens (McGurk, Jackson & Elia,
2013). Given that current nutrition screens have been unable to overcome such
challenges the potential utility of self-administered nutrition screens deserves further
exploration. Allowing individuals to facilitate their own routine nutrition screens would
enable them to become advocates for the maintenance of their nutrition status,
ensuring significant attention is given to identifying and addressing nutrition-related
concerns. Additionally, lack of human resources and heavy workloads of healthcare
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professionals would no longer be a barrier as self-administered nutrition screens would
be completed by the individuals being treated. This proactive approach would enable
early identification of nutritional concerns which could then be addressed, preventing
various malnutrition-related consequences and saving both time and money. Therefore,
it can be argued that an effective self-administered nutrition screening tool would
significantly benefit the clinical identification, monitoring, and management of
nutritional concerns associated with cancer. However, it must be noted that despite the
potential benefits of self-screens, caution must be taken during their implementation as
there would be concerns regarding their validity and reliability when completed by
certain populations of individuals (Cawood, Elia, Sharp, & Stratton, 2012).
When considering concerns regarding the validity and reliability of self-screening
instruments, attention must be directed to the potential for both over- and underreporting. For example, after contemplating their health state, individuals with HNCa
may become more attentive to factors which could be negatively influencing their
health and nutrition. Therefore, the potential for over- or under-reporting of such
variables may in part be dependent on their subjective interpretation of what is clinically
relevant (McClement, 2005). Additionally, though it is likely a lesser concern for physical
information, it remains a possibility that for a variety of individual reasons patients may
conceal this physical information. Recall bias may also lead an individual to misreport
screen information as various factors can influence an individual’s ability to recall
information (Coughlin, 1990). Thus, the added potential for bias and the occurrence of
either over- or under-reporting means that unintentional misreporting is an ongoing
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concern. Careful thought must be dedicated to assessing how these concerns may
present in specific populations of patients and how they can be accounted for.
Finally, the ideal nutrition screening instrument will have considered how the
prevalence rates of malnutrition may influence positive and negative predictive values.
This is because different cancer types, even different HNCa subgroups, are associated
with differing prevalence rates of nutritional concerns (Arends et al., 2016; Zekri et al.,
2014). Thus, the same tool will have differing predictive values dependent on the
prevalence rates of malnutrition in the particular patient population; positive predictive
values tend to increase with increasing prevalence rates, while negative predictive
values decrease. Conversely, with decreasing prevalence rates, positive predictive values
tend to decline while negative predictive values increase. Predictive values and how they
vary depending on the prevalence of nutritional concerns are important considerations
for healthcare providers. These values inform healthcare providers of the likelihood of a
patient with a positive result having the disease as well as one with a negative result not
having the disease. Thus, the psychometric properties of any screening tool and how
these can be influenced by prevalence rates must always be considered.
Assessment of Nutritional Status in HNCa
Any individual identified as at risk of malnutrition following a nutrition screen,
should undergo a complete assessment by a qualified professional (Davies, 2005;
Leuenberger et al., 2010; Meijers et al., 2010; Soeters et al., 2008). Nutritional
assessments provide an accurate definition of an individual’s nutritional status and a
foundation for future nutritional monitoring and interventions (Arends et al., 2016;
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Cushen et al., 2015; Ottosson et al., 2013a). Such measures aim to improve clinical
outcomes by addressing malnutrition when it presents, improve QOL, and reduce
adverse effects of anticancer treatments (Arends et al., 2016; Cushen et al., 2015).
Methods of Nutrition Assessment
Various nutrition assessments have been utilized within the cancer population,
each with strengths and weaknesses. Often the circumstances will dictate which method
of assessment is used, but inclusion of both objective and subjective parameters is
common. Nutrition assessments are laborious and comprehensive examinations of
nutritional concerns which combine nutrition information, past medical histories,
physical examinations, anthropometric measurements, and laboratory data (Mueller et
al., 2011). However, these assessment tools are not used at admission to hospital to
assess nutrition due to their complexity and the lack of resources needed for their
completion (Isenring et al., 2006; Smith, Smith, Ledgard, Doig, & Chesher, 2009). Thus, a
preference for less laborious nutritional assessment tools has emerged. Current
nutritional assessment methods commonly used for individuals with cancer include the
Subjective Global Assessment (SGA) and the Patient Generated-SGA (PG-SGA). Though
both are comprehensive nutrition assessments, the PG-SGA, developed by Ottery et al.,
was validated specifically for assessing the nutritional status of individuals with cancer.
SGA Nutrition Assessment
The SGA is a simple, cost-effective and easy-to-apply nutritional assessment tool
with fair-to-good predictive validity recommended by the ASPEN board of directors for a
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variety of patient groups (Gupta et al., 2011; Lis et al., 2012; Shirodkar & Mohandas,
2005; Platek, et al., 2015; van Bokhorst-de van der Schueren, Guaitoli, Jansma & de Vet,
2014). The SGA includes a comprehensive assessment completed by a healthcare
professional of symptoms which can influence nutritional intake, functionality and
physical capacity, dietary intake, and gastrointestinal symptoms (Lim et al., 2013). The
SGA also includes a physical examination of any muscle wasting, fat depletion, and
nutrition-related edema (Lim et al., 2013). Overall, the SGA is patient-centered,
incorporates the clinical history of the individual, and does not require laboratory testing
or medical imaging exams, easing its implementation (Gupta et al., 2011; Wakahara et
al., 2007). However, for SGA assessments to be reliable, they are required to be
performed by trained personnel and the grading depends on the accurate reporting of
the histories and physical observations of the individual being assessed (Wakahara et al.,
2007). This rigorous process has resulted in professional resistance to the regular
performance of the SGA upon hospital admittance (Leuenberger et al., 2010). Moreover,
the SGA is not sensitive enough to detect short-term changes in nutrition status (Bector,
Vagianos, Suh & Duerksen, 2016). Thus, the SGA has more often been used as a
reference standard against which other nutrition screening tools have been evaluated
(Cushen et al., 2015; Platek et al., 2015). Despite the positives of the SGA, it has inherent
limitations and also is not specific to individuals with cancer, leading to the
consideration of other assessment tools such as the PG-SGA.
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PG-SGA Nutrition Assessment
The Nutrition Dietetic Practice Group of the American Dietetic Association has
promoted the PG-SGA as the gold standard for nutritional assessments in oncology
(Gorenc et al., 2015). Many studies have also promoted the PG-SGA and it is commonly
utilized as a standard which other nutritional assessments and screens have been
evaluated against (Abe Vicente, Barão, Silva & Forones, 2013; Beck et al., 2015; Kim et
al., 2011). The PG-SGA is a simple tool adapted from the SGA and developed for
individuals with cancer. It has proven to be a sensitive, specific, and reliable tool for
predicting nutrition status as defined by the SGA (Cushen et al., 2015; Gorenc et al.,
2015; Gupta et al., 2011). The PG-SGA consists of a self-completed assessment of the
individual’s histories (weight, food intake, symptoms, and functioning) and a clinician
assessment of the metabolic demands of the disease, its impact on nutritional
requirements and a physical examination (Gorenc et al., 2015). Thus, the PG-SGA
enables quick nutrition assessments and allows the clinician to spend more time
addressing problems rather than gathering information (Gupta et al., 2011).
The PG-SGA utilizes two scoring methods. The continuous scoring method allows
for prioritization of those individuals in need of more urgent care, effectively allocating
limited resources, while the PG-SGA global rating scores (A, B, or C) give an overall
depiction of the individual’s nutrition status (Bauer et al., 2002; Gupta et al., 2011).
These scores are then linked to triage recommendations to guide the next steps of the
nutrition care process. Overall, the PG-SGA is less time intensive then the SGA, identifies
a more extensive range of nutrition impact symptoms and incorporates a scoring system
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which enables prioritization of individuals in most urgent need of care and effective
resource allocation (Bauer et al., 2002). For these reasons the PG-SGA has been the
most studied, validated, and commonly accepted nutrition assessment method for
individuals with cancer (Boléo-Tomé, Monteiro-Grillo, Camilo, & Ravasco, 2012; Cushen
et al., 2015). However, the PG-SGA still relies on the literacy of the individual performing
the assessment, is considered to be time-consuming, and requires examiner training
(Leuenberger et al., 2010). As such, the routine implementation of the PG-SGA in clinical
settings remains limited as there is neither time nor resources to regularly apply this
tool. It would, therefore, seem that the only way to ensure every individual who needs a
nutritional assessment receives one is to have assessments preceded by screens. Though
all individuals with HNCa would still undergo nutrition screens, only those identified as
being at nutritional risk would undergo the laborious and comprehensive nutritional
assessments, effectively utilizing and allocating limited human and financial resources.
Statement of Problem
Though various screening tools currently exist and have been used in oncology
settings, there has been little consistency in their clinical application and the compliance
to nutrition screening practices. The absence of a universal definition for malnutrition
makes it difficult to determine which screening tool produces the most accurate
classification of the problem (Isenring, & Elia, 2015; Meijers et al., 2010). This has meant
that the number of individuals identified as being at nutrition risk has depended on the
screening tool utilized, making comparisons between studies difficult. Without standard
nutrition guidelines regarding the identification of individuals at nutritional risk, the
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provision of nutritional interventions and how we monitor and follow-up will continue to
vary. Additionally, without clear guidelines, compliance to nutritional care practices in
oncology may remain low due to healthcare professionals lack of confidence in
malnutrition identification protocols (Spiro, Baldwin, Patterson, Thomas & Andreyev,
2006). This may result in the nutritional concerns of some individuals going
unrecognized in certain healthcare settings. Furthermore, healthcare resources are not
likely to be allocated to this important issue as long as the prevalence of malnutrition
varies based on the method used to identify it (Platek et al., 2011). This is especially true
for the outpatient HNCa population, a group that is currently underrepresented in
literature, as their nutritional concerns and challenges may be less apparent.
Without sensitive and specific screening tools, nutritional complications may
worsen. Though validated and more accurate nutrition assessment methods are
available such as the SGA and the PG-SGA, their routine implementation is impractical. It
is, therefore, important that alternative nutrition evaluation methods be explored such
as self-administered nutrition screens. Implementation of such screening tools could be
a step towards ensuring that every individual in need of nutrition care services receives
them. Consequently, the proposed study sought to improve the maintenance of the
nutritional status of outpatient individuals with HNCa by increasing compliance to
nutrition screening through validation of two self-administered nutrition screening tools
for this population. The self-screening tools selected were the PG-SGA short form (PGSGA SF) and the Pt-Global Application. These tools were compared to the PG-SGA to
assess their sensitivity, specificity and predictive values. Other objectives included the
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gathering of information on individual ability to perform self-screens as well as the
presence and extent of malnutrition-related concerns in the HNCa population and their
impacts on QOL.
Significance of Project
The literature promotes early and proactive nutritional interventions as these
cost-effective strategies prevent malnourishment more successfully than approaches
delayed until later stages of excessive weight loss (Baracos, 2006; Isenring, Bauer &
Capra, 2007; Langius et al., 2016; Prevost, Joubert, Heutte, & Babin, 2014; Ravasco,
Monteiro Grillo & Camilo, 2008; Uster et al., 2013). Additionally, studies have presented
conflicting conclusions regarding how interventions such as nutrition supplementation
(Baldwin & Weekes, 2012) and nutrition counselling (Arends et al., 2016; Platek, 2012;)
influences mortality rates, weight changes and energy intake when delayed until later
stages of treatment as the effectiveness of such methods depends on compliance to
nutritional regimens. Tube feeding, on the other hand, only inconsistently yields benefits
for individuals with cancer (Huhmann & August, 2009; Paleri & Patterson, 2010). It has
been associated with decreases in their willingness to consume food orally which can
result in muscle atrophy and late swallowing difficulties, leading to further nutritional
declines and reduced QOL (Paleri & Patterson, 2010; Reeve et al., 2016; Terrell et al.,
2004; Wells et al., 2016). Thus, nutritional interventions must be initiated early in order
to be most effective (Bloch, 2000; Capra et al., 2001; Piquet et al., 2002; Prevost et al.,
2014). The costs and risks associated with delaying nutrition interventions until later
stages of treatment outweigh the inconsistent benefits they produce. Standardized
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nutrition screening practices could enable proactive approaches for addressing
nutritional concerns and reduce the need for costlier and less effective nutrition
interventions later on.
Standardizing clinical nutrition screening has been outlined as a top priority of
the Canadian Malnutrition Task Force (Laporte et al., 2015). Standardized screens able
to overcome challenges associated with current screening tools would be beneficial in
terms of efficiency, safety, healthcare and QOL (Abbott et al., 2014; Lim et al., 2012;
Tappenden et al., 2013). A valid and efficient self-administered nutrition screening tool
for the outpatient HNCa population with acceptable sensitivity and specificity would
achieve this goal (Abbott et al., 2014; Larsson et al., 2005; Tappenden et al., 2013).
Additionally, the cost savings of nutritional screening protocols have been estimated to
be around $217 million annually according to Barents Group of KPMG Peat Marwick LLP
(1996), which has been supported by other studies (David, Bernstein & Coifman, 2013).
Thus, improving nutrition care practices for those at nutritional risk has been identified
as the fourth largest potential cost saving initiative by the National Institute for Health
and Care Excellence (2013). Cost savings of up to $1,500 per malnourished individual
have been identified in recent studies (Somanchi, Tao & Mullin, 2011). Though screening
practices may result in minor cost increases initially, these costs would be justified and
counteracted by reduced clinical expenses incurred attempting to correct the
malnutrition-related consequences individuals with HNCa experience later on (Abizanda
et al., 2016; Correia & Waitzberg, 2003; Norman, Pichard, Lochs, & Pirlich, 2008).
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Therefore, not only does screening benefit QOL and overall healthcare, but it can greatly
reduce healthcare expenditures.
However, as long as compliance to nutritional evaluations remains low, whether
due to the lack of efficient and validated screening tools or lack of standard nutrition
guidelines, proactive management of nutritional concerns will be difficult. Nutrition
evaluations in the oncology population will continually be overlooked or performed
inappropriately or too late. To prevent malnutrition and its associated consequences,
the development of new methods enabling routine nutrition screens are warranted
(Isenring et al., 2004; Tappenden et al., 2013). This is especially important in situations
where malnutrition is deemed to have high prevalence, such as in the HNCa population.

39

CHAPTER 2: METHOD
Participants
The population utilized in this study included both adult men and women
diagnosed with and treated for HNCa. Participants were between the ages of 30 and 80
years. The mean age of all participants was 61.8 (SD= 10.02). Of those who participated,
there were 26 males who had a mean age of 60.12 (SD=9.92, range 42 - 79 years) and 8
females who had a mean age of 67.375 (SD=9.47, range 50 - 80 years).
This study identified 37 individuals as potential participants of which 35
consented. The two participants who opted not to consent indicated that they were
unable enroll in the study due to time restrictions. Of the individuals who initially
consented to participate 32 completed the study on site while three selected to
complete the study at home and return it by mail. Of the three individuals who took the
package off-site, one male did not return it. Overall, complete study data were obtained
for 34 individuals (26 males and 8 females) resulting in a participation rate of 91.9%
(89.7% and 100% response rates for males and females, respectively). All participants
had been diagnosed with HNCa with exclusion of those with skin cancers.
Comprehensive demographic information of all participants is presented in Table 1.
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Table 1. Participant Demographic Information
Demographic Information, N=34
Male, n=
26, (76.5%)
60.116
(9.92)

Age - Mean (SD)
Married/
Partnered
18 (69%)
Current/Former
Alcohol
consumption
23 (88.5%)
Current/Former
Tobacco
consumption
21 (81%)
Occupational Status
Working
10 (38.5%)
Volunteer
Retired
Other

Female, n=
8, (23.5%)
67.375
(9.47)

Cancer Site

Oral Cavity

15 (44%)

5 (62.5%)

Larynx

11 (32.25%)

7 (87.5%)

Thyroid

3 (8.75%)

7 (87.5%)
2 (25%)

0

0

11 (42%)
5 (19%)

6 (75%)
0

Highest Level of Education Completed
Completed High
School
7 (27%)
2 (25%)
Some college/
post-secondary
5 (19%)
2 (25%)
Completed
college/ postsecondary
8 (31%)
1 (12.5%)
Graduate
Program
2 (7.5%)
1 (12.5%)
Other
4 (15.5%)
2 (25%)
Household Income ($)
<25,000
3 (11.5%)
25,000-50,000
6 (23%)
50,001-75,000
2 (7.5%)
>75,000
7 (27%)
Prefer not to say
8 (31%)

Treatment Information

1 (12.5%)
1 (12.5%)
2 (25%)
3 (37.5%)
1 (12.5%)
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Pharynx
5 (15%)
Treatment Modality
Surgery alone
16 (47%)
Surgery and
radiation
8 (23.5%)
Surgery, radiation
and chemotherapy
4 (11.75%)
Other
6 (17.75%)
Average Number of Months Since
Diagnosis
<6 Months

6 (17.75%)

6- <12 Months

4 (11.75%)

12- <18 Months

2 (5.75%)

18- <24 Months
4 (11.75%)
24- >24 Months
18 (53%)
Average Number of Months Since
Treatment Completion
Not yet completed
3 (8.75%)
<6 Months
7 (20.5%)
6- <12 Months
5 (15%)
12-<18 Months
4 (11.75%)
18-24 Months
15 (44%)

Initial Identification of Potential Participants
Primary physicians identified potential participants during the patient’s regular
clinical appointment at the London Health Sciences Centre, Victoria Campus, located in
London, Ontario. During this initial contact, the physician briefly outlined the purpose of
the study to the potential participant and referred them to the primary researcher if
they expressed interest in obtaining additional information and potentially participating.
The primary investigator then provided a complete description of the study as well as
full details regarding study involvement, including the risks, benefits, and potential
outcomes. Once individuals had been fully informed, they were asked if they would like
to consent to participating in the study. Upon written confirmation of consent patients
were given a letter of information, a support services contact list, a demographic
information sheet (Appendix C), two QOL surveys (the EORTC-QLQ-C30 and the EORTCQLQ-H&N35), two self-administered nutrition screens (the PG-SGA SF and the patient
completed portion of the Pt-Global App), and an ease-of-use questionnaire. Participants
also were asked to complete a PG-SGA nutrition assessment, including a brief noninvasive physical exam administered independently by a physician. Prior to commencing
the research and gathering of data from participants, ethical approval was obtained
from Western University’s Health Sciences Research Ethics Board (Appendix A).
Inclusion Criteria
As noted, all potential participants had to be between the ages of 30 and 80
years, were outpatients diagnosed and/or being treated for HNCa regardless of
treatment modality, and were between 3 months post-diagnosis and 24 months post42

treatment. In order to be included in the study, participants were also required by selfreport to be able to read, write, and understand English in order to understand
instructions, provide informed consent, and complete study tasks.
Exclusion Criteria
Participants with any form of skin cancer (basal cell, squamous cell, or
melanoma) were excluded as these cancers should not put a patient at an increased risk
of nutritional decline (Britton et al., 2016; Brown et al., 2013). Participants outside the
pre-determined age range or who were less than 3 months post-diagnosis or more than
24 months post-treatment also were excluded. Participants who were unable to read or
speak English were excluded as they may have experienced difficulty completing the
tasks necessary for the study. For similar reasons participants with severe physical
disabilities, dementia or other obvious cognitive impairments, or those who indicated
that their vision did not permit them to see the questionnaires were also excluded.
Measurement Instruments
Patient Generated – Subjective Global Assessment (PG-SGA) version 3.22.15
Prior to using this measure, written permission was obtained from its developer
(Dr. Ottery and the Pt-Global team at info@pt-global.org). These researchers are the
copyright holders of the PG-SGA, thus, approval was sought to utilize this nutritional
measurement tool through completion of the online permission form. The main purpose
for completion of this form is to maintain records regarding the usage of the PG-SGA.
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The PG-SGA comprises an assessment of the patient’s self-generated medical
histories (weight, food intake, symptoms, and activities and function) and a professional
assessment (including patient diagnosis, age, metabolic stress, and physical exam). The
PG-SGA utilizes a continuous scoring system, enabling the triaging and prioritization of
patients requiring more urgent treatment (Bauer, et al., 2002) as well as a Global
Assessment (categorizing patients as A= well-nourished, B= moderately malnourished or
suspected malnutrition, or C= severely malnourished). The PG-SGA yields a score from
“0” (no need for nutrition intervention) to “50” (immediate nutrition intervention
required). In the oncology setting a minimum score of one is assigned due to the
presence of the malignant disease while scores greater than or equal to nine indicate
critical need for symptom management and/or nutritional intervention. Prior research
has indicated that scores of 9 or greater have been identified as appropriate cut-offs for
the initiation of urgent nutrition intervention (Bauer et al., 2002).
The patient completed portion of the PG-SGA consists of 4 boxes regarding the
individual’s medical histories (Appendix F). In Box 1 (Weight) and Box 3 (Symptoms)
scores are additive and the final score is recorded. In Box 2 (Food intake) and Box 4
(Activities and Function) only one option corresponding to a particular score is selected
and recorded. The remaining portion of the PG-SGA is completed by a professional
(Appendix F). Box 5 (Disease and its relation to nutritional requirements) and Box 6
(Metabolic Demand) scores are additive while Box 7 (Physical Exam) is not. Box 7 is a
subjective rating of the total body deficit through a brief non-invasive physical exam.
The physical exam assesses three components of body composition (muscle, fat, and
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fluid status) for their degree of deficit. Subjective ratings given to each of these physical
components include “0” (no abnormality), “1+” (mild), “2+” (moderate), and “3+”
(severe). Based off of these subjective ratings an overall score for the entire physical
exam is given ranging from “0” (no malnourishment) to “3+” (severe malnourishment).
The PG-SGA has been accepted by the Oncology Nutrition Dietetic Practice Group
of the American Dietetic Association as the gold standard for nutrition assessment for
those with cancer (Bauer et al., 2002). In a study conducted by Bauer et al. (2002) the
PG-SGA was shown to have a sensitivity of 98%, specificity of 82%, and a positive and
negative predictive value of 95% and 93%, respectively. Additionally, the concurrent
validity between the PG-SGA and the original SGA was acceptable, with expected
correlations existing between PG-SGA scores, BMI and percentage weight loss in the
past six months (Bauer et al., 2002). Further, it was also shown that there was a low
internal consistency between the seven items of the PG-SGA indicating they were all
contributing fairly independently to the final scoring. Various studies have confirmed
that the PG-SGA has acceptable psychometric properties (Ravasco et al., 2003). Thus the
PG-SGA has demonstrated that it is a simple, efficient, valid and reliable nutrition
assessment tool which meets psychometric requirements, permitting its use for the
identification and triaging of malnourished oncology patients in clinical settings.
Patient Generated – Subjective Global Assessment Short Form (PG-SGA SF)
The PG-SGA SF, also referred to as the abridged PG-SGA, is entirely selfcompleted by the patient. The PG-SGA SF consists of four sections which are identical to
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the previously described patient completed portion of the current PG-SGA. Thus, the PGSGA SF includes four sections which cover the topics of weight history, food intake,
symptoms, and activity/functionality respectively. The PG-SGA SF utilizes a similar
continuous scoring system to output a triage score. However, as the professional portion
of the PG-SGA is not included on the PG-SGA SF, scores are adjusted and can range from
0 (no nutrition problems) to 36 (severe nutrition problems).
In studies performed by Gabrielson et al. (2013) and Abbott et al. (2016) the
validity of the PG-SGA SF has been assessed using heterogeneous groups of oncology
outpatients. The Gabrielson et al. (2013) study indicated that the PG-SGA SF, using a cutoff score of equal to or greater than seven to indicate nutritional compromise, yielded a
sensitivity of 94% and a specificity of 78%. Both studies concluded that the PG-SGA SF
appears to be a practical and effective nutrition screening tool for identifying nutrition
risk in oncology patients. However, these studies had heavy focuses on breast, colorectal
and gastrointestinal cancers and included only very few participants with HNCa. Thus,
the tools accuracy and sensitivity within the HNCa population when used as a self-screen
has not been well investigated. Consequently, further investigation into the applicability
of the PG-SGA SF in the HNCa population would appear to be warranted.
Pt-Global Application
The Pt-Global Application launched in 2014. It is a simplified and user friendly
version of the PG-SGA in an automated format which aims to streamline and increase
the ease of the nutrition screening process (Ottery et al., 2015). Like the PG-SGA, the Pt-
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Global Application also utilizes a continuous scoring system (0-50) and provides and
Global Assessment ranking (A, B, or C) which enables the triaging and prioritization of
patients as well as a summary of their overall nutritional status (Appendix G).
The Pt-Global Application consists of seven different sections. The first five
sections are self-completed by the patient. Section 1 (Patient) gathers information
regarding patient characteristics such as name, age, height and gender. Following this,
sections 2 through 5 are identical to the first 4 boxes of the PG-SGA and gather
information regarding weight history, food intake, symptoms, and activity/functionality,
respectively. The remainder of the Pt-Global App is to be completed by a healthcare
professional and section 6 (Professional portion) of the Pt-Global Application contains
three tabs which correspond to boxes 5, 6 and 7 of the PG-SGA. Thus, the remaining
three tabs examine the diagnosis, metabolic stress, and provides a brief non-invasive
physical examination. The final section of the Pt-Global Application is the Results section
where all calculations are completed automatically to yield the PG-SGA triage score and
overall Global Assessment category ranking. Additionally, colour coding indicates the
level of concern for each section (i.e., green indicates no concern whereas red indicates
high concern) and there is a BMI calculation based off of input height and weight.
Ottery et al. (2015) found that the Pt-Global Application had positive ratings on
items such as layout, user-friendliness, relevance and appropriateness. It was also found
that the majority of professionals, researchers, and laypersons who used the application
over the course of the study considered it appropriate for use in both clinical and
research settings (Ottery et al., 2015). Given that the Pt-Global App is simply an
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automated format of the original PG-SGA with a few additional features it is likely that
the sensitivity, specificity, and positive and negative predictive values will be very similar
to those of the paper based version of the PG-SGA.
The European Organization for the Research and Treatment of Cancer Quality
of Life Questionnaire (EORTC QLQ-C30)
The EORTC QLQ-C30 is a QOL questionnaire designed specifically for oncology
populations which covers the physical, emotional and social domains (Appendix D). The
website for the EORTC group is located at: http://groups.eortc.be/qol. The EORTC QLQC30 was designed to measure an individual’s self-perception of their QOL through a 30item questionnaire (Niezgoda & Pater, 1993). The first 28 questions assess symptoms
commonly reported by the oncology population as well as how these are influencing
their functioning and QOL. These questions utilize a scale which ranges from 1 to 4. A
score of “1” means that the indicated symptom is “not at all” influencing the individual’s
QOL while a score of “4” indicates the symptom is “very much” influencing their QOL.
Included are 3 symptomatic scales regarding fatigue (3 questions), nausea (2 questions),
pain (2 questions), 6 single questions evaluating dyspnea, sleeplessness, lack of appetite,
constipation, diarrhea and financial problems and an assessment of the five functional
scales: physical (5 questions), role (2 questions), emotional (4 questions), cognitive (2
questions) and social (2 questions) (Żmijewska-Tomczak et al., 2014). The final two
questions of the EORTC QLQ-C30 address global perceptions of the individual’s health
and QOL. These final two questions utilize a scale which ranges from “1” (a “very poor”
perception) to “7” (an “excellent” perception) (Żmijewska-Tomczak et al., 2014). The
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EORTC QLQ-C30 has been validated and displayed strong reliability and sensitivity to
change when assessing the QOL of individuals with different types of cancers including
head and neck (Bjordal & Kaasa, 1992; Osoba, Zee, Pater, Kaizer, & Latreille, 1994;
Sherman et al., 2000).
The European Organization for the Research and Treatment of Cancer Head
and Neck Cancer Module (EORTC QLQ- H&N35)
HNCa and common treatment modalities affect a variety of body functions and
can cause significant physical, emotional and social problems, considerably reducing
QOL. Therefore, the EORTC QLQ-H&N35 was developed by the EORTC Quality of Life
Group as a site specific module for the HNCa population (Appendix E). The EORTC QLQH&N35 is a QOL survey which has demonstrated strong reliability, validity and sensitivity
to change (Bjordal & Kaasa, 1992; Sherman et al., 2000;). It is a site-specific
questionnaire which assesses concerns commonly reported by individuals with HNCa.
The EORTC QLQ-H&N35 consists of 35 self-reported items which are divided into seven
subscales assessing pain (4 questions), swallowing (5 questions), senses (2 questions),
speaking (3 questions), social contact (4 questions), eating in the presence of others (4
questions), and sexuality (2 questions) (Żmijewska-Tomczak et al., 2014). Six single
questions then address issues such as teeth problems, problems opening the mouth,
dryness of the oral cavity, thick saliva, coughing, and feeling ill (Żmijewska-Tomczak et
al., 2014). The first 30 questions utilize a scale ranging from 1-4 to assess the influence
of the examined symptoms on the individual’s QOL. A score of “1” indicates that the
particular symptom or problem has “not at all” influenced their QOL while a score of “4”
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indicates that it has “very much” influenced their QOL. The final five questions are
scored in binary fashion as either “no” (1) or “yes” (2). These questions assess the
patient’s requirement for pain-killers, nutritional supplements or a feeding tube, as well
as whether the patient has lost or gained weight (Żmijewska-Tomczak et al., 2014). The
EORTC QLQ-H&N35 can be used in addition to the EORTC QLQ-C30 when assessing
symptoms and side effects of treatments influencing the QOL of individuals with HNCa
(Aaronson et al., 1993; Oskam et al., 2013; Żmijewska-Tomczak et al., 2014).
Ease-of-Use Questionnaire
The ease-of-use questionnaire used in this study is designed to assess the
participant’s perspective regarding their experience with the two self-completed
nutrition screening tools (PG-SGA SF & Pt-Global Application). The questionnaire consists
of 12 questions (Appendix F). The first 10 questions utilize a scale ranging from 1
(strongly disagree) to 5 (strongly agree) and assesses the participant’s impressions
regarding each of the tools organization, question difficulty, efficiency and simplicity.
The final two questions are response questions asking participants if they experienced
difficulties utilizing either tool or whether they had any suggestions for improvements.
Data Acquisition Procedure
The study population utilized within this project can be considered one of
convenience. Individuals meeting all inclusion and exclusion criteria were identified and
asked to participate in the study. Data collection occurred at the London Health Sciences
Centre, Victoria Campus, London, Ontario between February and May 2017. Those
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interested in participating in the study received an information letter briefly outlining
the study and its purpose, ethical guidelines, as well as the potential risks and benefits of
participation. After confirmation of consent, participants completed the demographic
survey and the two QOL surveys. Following this the two nutrition self-screening tools
were administered in a counter balanced manner to prevent the completion order of
the two screens from inadvertently introducing bias. Then finally, the ease-of-use
questionnaire was administered to gather patient perceptions regarding their user
experience with the two nutrition screening tools.
Participants either completed all self-administered forms on site or, if they were
unable to complete the forms at that time, took the package with them and returned
the forms by mail using pre-addressed and pre-stamped envelopes. However, despite a
portion of the package being able to be completed by study participants at home, the
nutritional evaluations were required to be completed on site as was the brief and noninvasive physical exam. This was because the materials required to complete the selfscreens and the physician required to administer the non-invasive physical exam could
only be found at this location. Remaining information from the professionally completed
sections of the PG-SGA were gathered by the researcher from charts. In order to
maintain confidentiality and de-identify personal information, participants were each
assigned a coded number assuring that they were not able to be personally identified
over the course of the study; this information was only accessible to the research team.
Participants were timed and observed as they completed the nutrition self-screens.
Information obtained from these nutrition self-screens was not disclosed to the
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professional who administered the PG-SGA nutrition assessment to prevent potential
bias. The entire process required an average of 21.3 minutes to complete (range = 15 to
35 minutes). In the case of those who completed the questionnaires outside of clinic,
the researcher asked the participant to provide the amount of time required for
completion prior to returning the completed packet of materials to the researcher.
Data Analysis
Descriptive and Comparative Statistics
Overall, and as described in earlier sections of this chapter, the study included
administration of the PG-SGA, the PG-SGA SF, the Pt-Global Application, the EORTC QLQC30, the EORTC QLQ- H&N35, an ease-of-use questionnaire and a demographic survey.
All participant scores were calculated according to the recommended procedural
guidelines for each measure. Global QOL, the five functioning scales and the nine
symptom scales from the EORTC QLQ-C30 were assessed and documented. The 18
symptom scales from the QLQ-H&N35 were also assessed and recorded. Additionally,
Global Assessment scores and triaging scores were obtained and recorded from each of
the nutrition measurement tools, the PG-SGA, the PG-SGA SF and Pt-Global App.
Descriptive statistics were used to outline and summarize participant characteristics
such as demographic and tumour/treatment related data. Factors such as gender, age,
treatment modality, cancer site, marital status, occupational status, educational
achievement and QOL scores were compared to nutrition status scores through the use
of comparative statistics. Additionally, comparative statistics were also utilized to
determine if any correlations existed between the scores obtained from the nutrition
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measurements and any of the domain scales of the EORTC QLQ-C30 or EORTC QOLH&N35. Parametric statistics including t-tests and Pearson correlation coefficients along
with nonparametric statistics such as Mann-Whitney U tests were performed in order
evaluate the differences between individuals classified as well-nourished versus
nutritionally compromised by the PG-SGA nutrition assessment.
Assessment of Reliability
The sensitivity, specificity, accuracy, and the positive/negative predictive values
(PPV/NPV) of the self-administered nutrition screening tools were calculated. Receiver
operating characteristic (ROC) curves were used to plot and assess the rates of true and
false positives of the nutrition screening tools compared to the PG-SGA nutrition
assessment. Briefly, ROC analyses assesses the sensitivity and specificity of a given test.
An area under the curve on the resulting plot of 1 represents a perfect test while an area
of 0.5 represents a test which is a poor measure of the given construct. As sample sizes
in the present investigation were assumed to be adequate, asymptotic significance tests
were utilized to identify the significance level of results obtained from the ROC analyses.
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CHAPTER 3: RESULTS
The following sections will present results obtained from the PG-SGA, the
nutrition screens (PG-SGA SF & Pt-Global Application), the ease-of-use survey, and the
QOL questionnaires (EORTC QLQ-C30 & EORTC QLQ-H&N35) gathered as part of this
study. Initially, descriptive statistics including measures of central tendency are reported
for items completed by participants. Following this, supplementary observational
analyses were made assessing nutrition trends associated with demographic factors
such as participant age, treatment modality, and smoking status.
Comments provided by participants on open-ended questions on both the
demographic information survey and the ease-of-use survey have also been summarized
to identify topics/issues which they felt were important. The intention behind this was
to better our understanding of the experience of individual participants.
Patient Generated – Subjective Global Assessment (PG-SGA)
Of the 34 participants, 23 (18 males and 5 females) were identified by the PGSGA as having good nutrition status (Category A), 9 (6 males and 3 females) had a
moderately compromised nutrition status (Category B), while 2 males were identified as
having severely compromised nutrition status (Category C). Thus, nutritional
complications, classified as either Category B or C, were present in 32.3% of participants
(30.7% of males and 37.5% of females). Although the majority of participants presented
as being well-nourished, this does not imply that the remaining nutritional issues that
emerged were any less concerning. Specifically, for those participants who presented
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with a compromised nutrition status, many were found to be moderately malnourished
(M = 11; range 7-17). Detailed participant responses are presented in Table 2.
Table 2 provides the mean scores calculated for each of the 4 boxes of the
patient completed portion PG-SGA, as well as for the final professionally completed
portion. Results have been segregated by nutrition status. It can be seen that the
nutritionally compromised individuals had higher mean scores than did the wellnourished individuals on all assessment boxes (indicating a worse nutrition status). The
greatest difference was observed for box 3 “symptoms influencing nutrient
consumption”. The most commonly reported nutrition impact symptom identified was
“dry mouth”, followed closely by “lack of appetite” and an “impaired sense of taste”.
The least commonly reported nutrition impact symptoms were “vomiting” and an
“impaired sense of smell”.
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Table 2. PG-SGA Assessment Score
Score Summary
WN
NC
(n=23)
(n=11)
Males
18
8
Females
Mean Box 1
Mean Box 2
Mean Box 3
Mean Box 4

5
0.04
0.35
0.52
0.39

3
0.36
1.45
6
1.36

Mean Professional
1.52
2.18
Score
Mean PG-SGA
2.83
11.36
Score
Average Category
A
B
Weight Change in Past 2 Weeks
Increased
7
4
(30.5%) (36.5%)
Unchanged
15 (65%)
5
(45.5%)
Decreased
1 (4.5%) 2 (18%)

Nutrition Impact Symptoms
P-Value
No Problems Eating

0.282
0.019*
1.78x10-4 *
1.39x10-4 *
0.014*
2.00x10-6 *

2 (8.5%)

Unchanged

21
(91.5%)
0

Normal food, but
less than normal
amount
Little solid food

4
(17.5%)

3
(27.5%)
5
(45.5%)
3
(27.5%)
3
(27.5%)

2 (8.5%)

3
(27.5%)

Only nutritional
Supplements

0

0

Only liquids

0

1 (9%)

Very little of
anything
Only tube feedings
or nutrition by vein

0

1 (9%)

2 (8.5%)

0

15 (65%)

3
(27.5%)

None Selected

0

Funny/No Smell

0
0
2
(8.5%)
0

0
1 (9%)
7
(63.5%)
0

Feels Full Quickly

0

5
(45.5%)
4
(36.5%)
1 (9%)

Swallowing Problems
Pain

Fatigue

More than usual

NC
(n=11)
1 (9%)
8 (73%)
1 (9%)
2 (18%)
1 (9%)
6
(54.5%)
3
(27.5%)
2 (18%)

Vomiting
Diarrhea
Dry Mouth

Food Intake

Less than usual

No Appetite
Nausea
Constipation
Mouth Sores
Funny/No Taste

WN
(n=23)
16
(69.5%)
0
0
0
0
2
(8.5%)
3 (13%)

Other

1
(4.5%)
0

Activities and Function
Normal with no limitations
Not normal self, but able to
be up and about with fairly
normal activities
Not feeling up to most
things, but in bed or chair
less than half the day
Able to do little activity and
spend most of the day in
bed or chair
Pretty much bed ridden,
rarely out of bed

*Well-Nourished (WN), Nutritionally Compromised (NC).
56

14
(61%)
9 (39%)

1 (9%)
6
(54.5%)

0

3
(27.5%)

0

1 (9%)

0

0

Patient Generated – Subjective Global Assessment Short Form (PG-SGA SF)
Mean scores for the PG-SGA SF were calculated and are presented in Table 3. Of
the 34 participants, 25 individuals (20 males and 5 females) were identified by the PGSGA SF as being well-nourished (Category A), while 9 (6 males and 3 females) were
identified as being nutritionally compromised (Category B or C). Thus, nutritional
concerns were present in 26.47% of participants (23.08% of males and 37.5% of females)
and scores ranged from 0 - 15. For the nutritionally compromised group, the majority
were moderately malnourished with a mean nutrition score of 10.22. In contrast, those
identified as being well-nourished had a mean nutrition score of 1.56. The PG-SGA SF
also agreed with the PG-SGA, identifying “dry mouth” as the most common nutrition
impact symptom, followed by “lack of appetite” and an “impaired sense of taste” while
the least common were “vomiting” and an “impaired sense of smell”. On average the
PG-SGA SF took participants 1.82 minutes to complete.
Overall, the PG-SGA SF showed good agreement with the PG-SGA and
demonstrated a sensitivity of 81.8% and a 100% specificity. Additionally, the positive
predictive value of the PG-SGA SF was 100%, while the negative predictive value was
92%. A ROC analysis revealed an area under the curve of 0.982 (with lower and upper
bound score 0.943 and 1.000, respectively). An asymptotic significance test then
identified an a priori significance level of p=7.0 x 10-6. Further details regarding this ROC
curve analysis can be found in Figure 1. Thus, the PG-SGA SF demonstrated acceptable
levels of accuracy as well as a strong ability to predict PG-SGA nutrition scores and
nutrition category ratings.
57

Table 3. PG-SGA SF Screen Scores
Score Summary

Males
Females
Mean Box 1
Mean Box 2
Mean Box 3
Mean Box 4

Nutrition Impact Symptoms
WN
(n=25)
20
5
0.04
0.52
0.56
0.44

NC
(n=9)
6
3
0.44
1.22
7.11
1.44

Mean PG-SGA SF
1.56
10.22
Score
Average Category
A
B
Weight Change in Past 2 Weeks
Increased
7 (28%)
4
(44.5%)
Unchanged
17
3
(68%)
(33.5%)
Decreased
1 (4%) 2 (22%)
Food Intake
More than usual
Unchanged
Less than usual

P-value

0.268
0.079*
1.20x10-5 *
2.27x10-4 *
3x10-6 *

No Problems Eating
No Appetite
Nausea
Constipation
Mouth Sores
Funny/No Taste

WN
(n=25)
17 (68%)
0
0
0
0
2 (8%)

Swallowing Problems

3 (12%)

Pain
Vomiting
Diarrhea

3 (12%)

2 (22%)

Fatigue

2 (8%)

22
(88%)
0

4
(44.5%)
3
(33.5%)
3
(33.5%)

Other

1 (4%)

6
(66.5%)
0
5
(55.5%)
3
(33.5%)
0

15 (60%)

0

Not normal self, but able
9 (36%)
to be up and about with
fairly normal activities
Not feeling up to most
1 (4%)
things, but in bed or chair
less than half the day
Able to do little activity
0
and spend most of the day
in bed or chair
Pretty much bed ridden,
0
rarely out of bed
Agreement with PG-SGA Assessment

Normal food, but
less than normal
amount
Little solid food

4 (16%)

3 (12%)

2 (22%)

Only liquids

1 (4%)

0

Only nutritional
Supplements

0

0

Very little of
anything
Only tube feedings
or nutrition by vein
None selected

0

1 (11%)

2 (8%)

0

15
(60%)

3
(33.5%)

Dry Mouth

0
0
0

Funny/No Smell
Feels Full Quickly

3 (12%)

NC
(n=9)
0
8 (89%)
1 (11%)
2 (22%)
1 (11%)
6
(66.5%)
3
(33.5%)
2 (22%)
0
1 (11%)

0
0

Activities and Function
Normal with no limitations

Sensitivity

81.8%

Specificity
Positive Predictive Value
Negative Predictive Value

100%
100%
92%

* Well-Nourished (WN), Nutritionally Compromised (NC).
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6
(66.5%)
2 (22%)

1 (11%)

0

Figure 1. PG-SGA SF Receiver Operating Curve (ROC)

Legend
___ PG-SGA
SF ROC curve
___ Reference
Line

Pt-Global Application
Mean scores for the Pt-Global Application were calculated and are presented in
Table 4. The Pt-Global application identified 7 of 34 study participants (4 males and 3
females) as being nutritionally compromised (Category B or C), while 27 (22 males and 5
females) were identified as well-nourished (Category A). Thus, the Pt-Global Application
identified nutritional complications in 20.6% of participants (15.4% of males and 37.5%
of females) with scores ranging from 0 - 13. For those who presented with a
compromised nutrition status, the mean nutrition score was 9.71; those identified as
well-nourished presented with a mean score of 1.7. The most commonly reported
nutrition impact symptoms on the Pt-Global application were, “dry mouth” and “lack of
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appetite”, while the least reported symptoms were “vomiting” and “diarrhea”. On
average the Pt-Global Application took participants 3.71 minutes to complete.
Overall, the Pt-Global Application demonstrated fair agreement with the PG-SGA
demonstrating a sensitivity of 63.6% and a specificity of 100%. Additionally, the positive
and negative predictive values of the Pt-Global Application were identified to be 100%
and 85.2%, respectively. Again, an ROC curve analysis was performed which identified an
area under the curve of 0.962 (with lower and upper bound scores of 0.904 and 1.000,
respectively). The following asymptotic significant test revealed a significance of p=1.7 x
10-5. Further details regarding this ROC curve analysis can be found in Figure 2. Thus, the
Pt-Global Application demonstrated a moderate ability to predict PG-SGA nutrition and
category ratings, and accuracy ratings all reached acceptable levels with the exception of
sensitivity which fell below the 80% benchmark value.
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Table 4. Pt-Global Application Screen Scores
Score Summary
WN
NC
(n=27)
(n=7)
Males
22
4
Females
5
3
Mean Box 1 Score
Mean Box 2 Score
Mean Box 3 Score
Mean Box 4 Score
Mean Pt-Global
Score
Average Category

0.04
0.52
0.63
0.52
1.7

0.57
1.14
6.43
1.57
9.71

A

B

Weight Change in Past 2 Weeks
Increased
9 (33%)

Nutrition Impact Symptoms
P-value

6.090
0.136
0.002*
0.001*
1.46x10-4 *

2
(28.5%)
3 (43%)

Unchanged

17 (63%)

Decreased

1 (3.5%)

2
(28.5%)

Food Intake
More than usual
Unchanged

2 (7.5%)
24 (89%)

Less than usual
Normal food, but
less than normal
amount
Little solid food

1 (3.5%)
5 (18.5%)

1 (14%)
2
(28.5%)
4 (57%)
4 (57%)

3 (11%)

0

Only liquids

1 (3.5%)

0

Only nutritional
Supplements

0

0

Very little of
anything
Only tube feedings
or nutrition by vein
None selected

0

1 (14%)

2 (7.5%)

0

16
(59.5%)

2
(28.5%)

No Problems Eating
No Appetite

WN
(n=27)
20 (74%)
1 (3.5%)

Nausea
Constipation
Mouth Sores
Funny/No Taste
Swallowing Problems

0
0
0
2 (7.5%)
3 (11%)

Pain

0

Vomiting
Diarrhea

0
0

Dry Mouth

2 (7.5%)

Funny/No Smell

0

5
(71.5%)
1 (14%)

Feels Full Quickly
Fatigue
Other

1 (3.5%)
2 (7.5%)
1 (3.5%)

3 (43%)
1 (14%)
0

Activities and Function
Normal with no
limitations

15
(55.5%)

0

Not normal self, but able 10 (37%)
to be up and about with
fairly normal activities
Not feeling up to most
2 (7.5%)
things, but in bed or
chair less than half the
day
Able to do little activity
0
and spend most of the
day in bed or chair
Pretty much bed ridden,
0
rarely out of bed
Agreement with PG-SGA Assessment
Sensitivity

63.6%

Specificity
Positive Predictive Value
Negative Predictive
Value

100%
100%
85.2%

* Well-Nourished (WN), Nutritionally Compromised (NC).
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NC
(n=7)
1 (14%)
6
(85.5%)
1 (14%)
1 (14%)
1 (14%)
3 (43%)
2
(28.5%)
2
(28.5%)
0
0

4 (57%)

2
(28.5%)

1 (14%)

0

Figure 2. Pt-Global Receiver Operating Curve (ROC)

Legend
___ Pt-Global App
ROC curve
___ Reference
Line

Ease-of-Use Survey
The mean, mode, median, range, and standard deviations for the 10 questions
presented on the ease-of-use survey are summarized in Table 5. Recall that higher
scores indicate a greater level agreement with the statement. What is clear based on
these data is that the current participants preferred the PG-SGA SF over the Pt-Global
Application. Mean scores for all questions asked on the ease-of-use survey were higher
for those regarding the PG-SGA SF. This indicates that participants were commonly in
stronger agreement with the statements for the PG-SGA SF than for the Pt-Global
Application.

62

Table 5. Ease-of-Use Survey Scores
N
PG-SGA SF
Q1. Easy to use
34
Q2. Organized in
understandable way
34
Q3. Easy to understand
34
Q4. Able to be completed
quickly with ease without
professional aid
34
Q5. Simple tool for assessing
nutrition status
34
Pt-Global App
Q6. Easy to use
34
Q7. Organized in
understandable way
34
Q8. Easy to understand
34
Q9. Able to be completed
quickly with ease without
professional aid
34
Q10. Simple tool for assessing
nutrition status
34

Range

Mean

Mode

Median SD

1-5

4.11

4

4

0.84

1-5
1-5

4.29
4.29

4
4

4
4

0.68
0.678

1-5

3.97

4

4

1.11

1-5

3.97

4

4

0.834

1-5

3.76

4

4

1.13

1-5
1-5

4.06
4

4
4

4
4

0.98
0.95

1-5

3.76

4

4

1.3

1-5

3.74

4

4

0.99

Results of the EORTC QLQ-C30
The mean, range, and standard deviation scores for each of the 30 questions
included on the EORTC QLQ-C30 were calculated. These scores were then segregated by
nutrition status to highlight differences between the QOL scores of the well-nourished
and nutritionally compromised groups. Items were scaled from 1 (“not at all a problem”)
to 4 (“very much a problem”). An arbitrary level of significant difference between wellnourished and nutritionally compromised means was set at 0.5. For both the wellnourished and nutritionally compromised groups, Question 18 “were you tired” received
the highest mean score of 1.78 and 2.55, respectively. For the well-nourished group,
Question 5 “did you need help eating, dressing, washing yourself or using the toilet”
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received the lowest mean score of 1. This differed from the nutritionally compromised
group who indicated that Question 15 “have you vomited” was their least concerning
problem (M = 1). What is important to note is that for every item the score of the
nutritionally compromised group was either similar to or greater in value when
compared to the well-nourished group. These scores suggest that the nutritionally
compromised individuals are having their perceived QOL influenced by these factors to a
greater degree than the well-nourished group.
Detailed measures of central tendency for each of the EORTC QLQ-C30 domains
(Global QOL, physical, role, emotional, cognitive and social functioning, fatigue, nausea,
pain, dyspnoea, insomnia, appetite loss, constipation, diarrhea and financial difficulties)
are presented in Table 6; again, these data have been segregated by nutrition status.
Domain scores could range from 0 (worst possible functioning) to 100 (best
possible functioning). Well-nourished participants physical functioning revealed the
highest mean domain score (92.17) while their emotional functioning had the lowest
mean score (82.25). In contrast, the nutritionally compromised individuals reported that
their role functioning was best (M = 72.12) while their social functioning was the worst
(M = 56.06). Most importantly for the present study, significant differences were
observed between the physical, cognitive and social functioning domains of the wellnourished and nutritionally compromised groups. In each instance, the perceived QOL of
the nutritionally compromised group was worse.
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This trend toward a worse perceived QOL for the nutritionally compromised
group held true for all the symptoms scale scores as well, with the exception diarrhea
which was insignificant. Symptom scales also had the possibility to range from 0 (not at
all a problem) to 100 (very much a problem). Those individuals identified as nutritionally
compromised also reported experiencing a greater degree of QOL impact on the C30,
with “fatigue”, “appetite loss”, and “constipation” reaching significance. The symptom
reported to have the greatest influence on QOL for the nutritionally compromised group
was “appetite loss” (M = 42.42), while “nausea” was the least influential (M = 4.55).
Additionally, the mean Global QOL domain scores for the well-nourished and
nutritionally compromised groups differed significantly. This revealed that when
individual perceptions of personal Global QOL were compared, the nutritionally
compromised group perceived their QOL to be significantly worse.
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Table 6. EORTC QLQ-C30 Domain/Symptom Scores
N
Range
Mean
Median
WN NC
WN
NC
WN
NC
Global Health
Status
Global QOL
23 11 0-100 78.62 55.3 83.33 58.33
Functional
Domain Scales
Physical
23 11 0-100 92.17 72.12 93.33 73.33
Role
23 11 0-100 86.23 72.73 100 83.33
Emotional
23 11 0-100 82.25 70.45 83.33 66.67
Cognitive
23 11 0-100 91.3 63.64 100 66.67
Social
23 11 0-100 86.23 56.06 100 66.67
Symptoms/Items
Fatigue
23 11 0-100 20.29 38.38 22.22 44.44
Nausea
23 11 0-100 3.62 4.55
0
0
Pain
23 11 0-100 18.11 31.82 16.67 33.33
Dyspnoea
23 11 0-100 11.59 27.27
0
33.33
Insomnia
23 11 0-100 24.64 30.3 33.33 33.33
Appetite loss
23 11 0-100 4.35 42.42
0
33.33
Constipation
23 11 0-100 4.35 30.3
0
33.33
Diarrhea
23 11 0-100 7.25 6.06
0
0
Financial
23 11 0-100 13.04 33.33
0
0
* Well-Nourished (WN), Nutritionally Compromised (NC).

SD

P-value

WN

NC

14.5

16.75

3.44x10-4*

11.57
20.01
17.94
10.85
21.23

17.19
32.32
22.19
14.91
32.53

0.001*
0.155
0.124
4.00x10-6*
0.003*

16.92
9.78
21.93
18.67
28.18
11.23
11.23
13.75
19.01

19.75
10.67
24.09
31.45
37.86
37.11
36.51
13.33
43.33

0.016*
0.808
0.125
0.087
0.632
0.010*
0.048*
0.817
0.175

Results of the EORTC QLQ-H&N35
The means, ranges, and standard deviations for the 35 questions of the EORTC
QLQ-H&N35 were calculated; again, scores were segregated by nutrition status for
comparison. Scores ranged from 1 (“not at all a problem”) to 4 (“very much a problem”)
for the first 30 items. An arbitrary level of significant difference between well-nourished
and nutritionally compromised means was set at 0.5. For the nutritionally compromised
group Question 7, “have you had problems swallowing solid food?” received the highest
mean score of 2.91 while Question 4, “have you had a painful throat?”, received the
lowest mean score of 1.09. Questions 31-35 were excluded from consideration as these
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questions utilize a different rating scale. Of importance for this study is the finding that
in every instance where a significant difference was observed between H&N35 items,
the greater QOL impact was reported by the nutritionally compromised group.
Detailed measures for each of the symptom domains are summarized in Table 7.
Symptom domains had the potential to range from 0 (“not at all afflicting”) to 100
(“completely afflicting”). For the nutritionally compromised group, “dry mouth”
presented the highest mean score (M = 57.56) while “pain” had the lowest mean score
(M = 9.8). What is again important to point out is that with exception of “pain”,
“nutritional supplements” and “weight gain”, none of which achieved significance, all
H&N35 symptom domain scores received higher ratings from the nutritionally
compromised group, indicating a greater perceived influence. Significant differences
were observed between the scores of the “senses” and “speech problems” domains as
well as the “teeth” and “dry mouth” domains. Additional domains which approached
significance which had face value for nutrition status were “swallowing”, “trouble with
social eating” and “social contact” and “sticky saliva”.
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Table 7. EORTC QLQ-H&N35 Symptom Scores
N
Range
Mean
WN NC

WN

NC

Median
WN

NC

Symptoms
scales/items
Pain
23 11 0-100 14.49 9.85 16.7
0
Swallowing
23 11 0-100 15.22 31.06 8.33
25
Senses
problems
23 11 0-100 10.14 42.42
0
50
Speech
problems
23 11 0-100 20.77 40.4 11.1 33.33
Trouble with
social eating 23 11 0-100 13.41 31.82
0
25
Trouble with
social
contact
23 11 0-100 8.99 28.48
0
20
Less
sexuality
23 11 0-100 20.29 27.27
0
0
Teeth
23 11 0-100 14.49 42.42
0
33.33
Opening
mouth
23 11 0-100 11.59 30.3
0
33.33
Dry mouth
23 11 0-100 24.64 57.56
0
66.67
Sticky saliva
23 11 0-100 14.49 33.33
0
33.33
Coughing
23 11 0-100 24.64 39.39 33.3 33.33
Felt ill
23 11 0-100
5.8 18.18
0
0
Pain killers
23 11 0-100 34.78 54.55
0
100
Nutritional
supplements 23 11 0-100 30.43 27.27
0
0
Feeding
tube
23 11 0-100 13.04 18.18
0
0
Weight loss
23 11 0-100
8.7 27.27
0
0
Weight gain 23 11 0-100 30.43 18.18
0
0
* Well-Nourished (WN), Nutritionally Compromised (NC).

SD
WN

PValue
NC

14.79 14.13
22.74 20.13

0.405
0.065

14.53 28.75 0.005*
23

28.53 0.045*

26.89 21.85

0.064

15.18 27.43

0.055

31.83 37.11 0.587
25.68 32.07 0.012*
18.67
29.84
23.73
26.41
12.63
47.63

33.2 0.120
35.08 0.010*
28.42 0.058
31.2 0.173
21.85 0.119
49.79 0.287

46.01 44.54
33.68 38.57
28.18 44.54
46.01 38.57

0.855
0.703
0.245
0.464

Consistency of Responses
Participant’s responses for both EORTC surveys and the nutrition evaluations
demonstrated consistency. When individuals reported a better perceived global QOL
and nutrition status, other domains tended to also be rated highly. Conversely, when
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individuals indicated that the had a lower perceived Global QOL and nutrition status,
they tended to report a worse perceived functioning and an increased symptom burden.
Correlation Assessment of Measures
The scores for global QOL, the five functional domains, and 12 of the 27
symptom scales from both EORTC measures, as well as PG-SGA scores were compared
to identify potential relationships. This correlational assessment revealed moderate-tostrong relationships between various measures (Table 8).
A moderate inverse relationship was identified between the PG-SGA scores and
the Global QOL scores, r(32) = -0.5, p<0.01. Thus, with increasing nutritional concerns,
QOL scores tended to decline. Moderate-to-strong relationships were also identified
between the PG-SGA nutrition scores and many EORTC functional domains, the
strongest of which was identified for the physical functioning domain, r(32) = -0.63,
p<0.01. As for the item/symptom scales, the strongest correlations with the PG-SGA
nutrition scores were found for loss of appetite, r(32) = 0.58, p<0.01, constipation, r(32)
= 0.56, p<0.01, and senses problems, r(32) =0.6, p<0.01. Remaining values identified by
the correlational analysis can be found in Table 8.
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Table 8. Correlation Matrix
GPGQOL
SGA
Global
Health
PG-SGA
Score
Physical
Role
Emotional

1

PF

RF

EF

CF

SF

F

N&V

A

C

S

SP

TSE

T

OM

DM

SS

FI

.504**

.510**

.568**

.652**

.504**

.653**

.582**

-0.092

-.426*

.505**

-.439**

-.473**

-.480**

-.628**

-.394*

.579**

-.341*

.510**

1

.627**

-0.242

-0.241

.532**

.512**

.390*

0.111

.582**

.564**

.401*

.599**

.443**

.395*

.368*

.437**

0.301

.400*

1

.474**

.514**

0.335

.498**

0.023

-.418*

1

.700**

.485**

.571**

-0.107

-.427*

1

.439**

.708**

-0.326

-0.162

1

.450**

-0.334

Cognitive
Social
Fatigue
Nausea &
Vomiting
Appetite
Loss
Constipation

1

.606**
.695**
.789**
.488**
.525**
1

.673**
.550**
.457**

-0.315

-.493**

-.399*

-.373*

-0.066

-.419*

-0.275

0.284

-.464**

-.374*

-.661**

-.395*

-0.309

-.400*

-0.292

-.416*

-0.224

-0.215

-.492**

-.761**

-.376*

.552**

-0.143

.510**

-0.284

-.364*

-.499**

-.374*

-.390*

.476**

-0.323

-0.289

-0.250

-0.291

.505**

-0.338

-0.189

-.562**

-.669**

-.344*

.620**

-0.305

.375*

.483**

.564**

0.300

.429*

.413*

.488**

0.258

.603**

.345*

.596**

1

0.223

-0.132

0.257

0.101

0.129

0.072

0.176

0.305

0.187

.730**

1

.412*

.426*

.703**

0.223

0.108

.343*

.347*

.476**

0.323

1

.349*

0.251

.486**

0.283

0.154

.553**

.379*

0.236

1

.464**

.709**

0.073

0.328

0.292

.641**

0.320

1

.407*

0.196

.469**

0.175

.411*

0.287

1

0.299

.450**

.376*

0.321

.492**

1

.422*

.470**

0.007

.428*

1

.393*

0.277

.566**

1

.442**

.562**

1

0.200

Swallowing
Senses
Problem
Trouble
Social Eating
Teeth
Opening
mouth
Dry mouth
Sticky Saliva
Felt ill

.651**
.535**
.593**

1

**. Correlation is significant at the 0.01 level (2-tailed).
*. Correlation is significant at the 0.05 level (2-tailed).
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Supplemental Observational Analysis of Data
Gender Comparisons
Scores between male and female participants were compared for the Global
QOL and PG-SGA measures. During these comparisons, statistically significant
differences were not found between any of these measures based on gender.
Treatment modality
The types of HNCa treatments received varied and tended to have an
influence on the participants’ nutrition status. The first analysis assessed whether
there was a difference between the nutrition scores of those participants who
received surgery alone as a treatment (range= 1 – 14) vs. other types of treatment
such as chemotherapy, radiation therapy or a combined modality (range= 2 - 17). A ttest indicated that there was a significant difference between groups (t(33)=2.75,
p<0.01). An additional t-test also indicated a significant difference between the QOL
of the two groups (t(33)=3.95, p<0.001). Those who received surgery alone had a
mean PG-SGA score of 3.88, while those who received any other individual treatment
type or a combination of treatments had a mean PG-SGA score of 7.29. Figure 3
presents a detailed list of PG-SGA nutrition scores by treatment modality. A MannWhitney U test revealed significant differences for the PG-SGA nutrition assessment
scores, U(33)=64, p<0.01, across the different treatment modality categories.
Further, an additional Mann-Whitney U test identified significant differences for
Global QOL scores, U(33)=48.5, p< 0.01, across treatment modality categories. No
significant differences between the categories of treatment modality for the variable
of time post treatment were observed.
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Figure 3. PG-SGA Scores by Treatment Modality
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Smoking status
A t-test was used to identify if there was a significant difference between the
mean PG-SGA nutrition scores of current and former smokers compared to nonsmokers (6.11 and 3.17, respectively). This test did identify a level of significant
difference between the two groups (t(33)=2.58, p<0.05). Next current and former
smoking groups were differentiated (Figure 4). Participants who indicated that they
had never smoked, tended to have lower PG-SGA scores (range = 1 – 5), while those
who indicated they were former smokers tended to present with the highest PG-SGA
scores (range = 1-17) and thus higher nutritional concerns.
Figure 4. PG-SGA Scores by Smoking Status
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Age
A correlational assessment between participant age and PG-SGA assessment
scores revealed that nutrition scores increased with age (indicating a worse overall
nutrition status) and this relationship is depicted in Figure 5. The Pearson correlation
between age and PG-SGA nutrition score was r(32)=0.48, p<0.01. The correlation
between age and the Global QOL domain scores however, was insignificant.
Figure 5. PG-SGA Scores by Participant Age
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Summary
The present investigation assessed the ability of the PG-SGA SF and Pt-Global
Application to predict PG-SGA nutrition assessment scores. All accuracy ratings for
both screening tools achieved the 80% acceptability benchmark with the exception of
Pt-Global sensitivity. Following this, EORTC scores of those identified as wellnourished were compared to those identified as nutritionally compromised. Various
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items achieved significant levels of difference with worse QOL scores reported by the
nutritionally compromised group. There did prove to be significant correlations
between nutrition and QOL measures. As nutrition scores increased (greater
nutritional concerns) QOL ratings decreased, functional domain scores declined, and
symptom domain scores increased. Finally, significant differences were found to exist
between the nutrition scores of individuals based on their treatment modality,
smoking status, and age.
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CHAPTER 4: DISCUSSION
The purpose of the present investigation was to assess the accuracy of two
nutrition self-screening tools when compared to the PG-SGA. This allowed for the
determination of whether either self-screening tool could be reliably used to
efficiently and proactively identify individuals at nutritional risk. Additionally, the
relationship between the nutrition status and QOL of individuals diagnosed and
treated for HNCa on an outpatient basis was assessed. This study also aimed to
identify the common nutritional concerns following HNCa treatment. Various
nutrition impact symptoms, functional domains and the interrelations between the
two were examined. Thus, the specific questions targeted in this study were:
1) Are nutritional self-screens able to be reliably completed by outpatients with
HNCa and are the results comparable to those of nutritional assessments?
2) What are the commonly reported symptoms impacting the nutrition status of
individuals with HNCa being treated on an outpatient basis?
3) What is the relationship between nutrition status and overall QOL among
individuals diagnosed with HNCa being treated on an outpatient basis?
Throughout the following sections of this discussion these questions, as well as
the specific issues that arose from the data obtained will be addressed. This will
begin with a discussion of the findings gathered from the statistical analyses of the
PG-SGA nutrition assessment and both nutrition screening tools. This will include
how the nutrition screens related to the PG-SGA, identification of commonly
reported nutrition impact symptoms, and how responses differed between the wellnourished and nutritionally compromised. Following this, results from the statistical
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analysis of both QOL surveys (EORTC QLQ-C30 and EORTC QLQ-H&N35) will be
outlined. The relationship between nutritional status and QOL and how the various
domains differed between well-nourished and nutritionally compromised individuals
will be discussed. The final sections of this chapter will outline the study limitations,
the potential clinical implications, and the possible directions for future research into
self-administered nutrition screening in those with HNCa.
Patient Generated – Subjective Global Assessment (PG-SGA)
Recall that the PG-SGA was specifically designed to assess the nutritional
status of individuals with cancer. However, due to limitations such as time
restrictions and heavy workloads of healthcare professionals, its routine
implementation has been suggested to be impractical. However, for research and
comparison purposes it remains a validated nutrition assessment for the cancer
population (Abe Vicente et al., 2013).
Based on the PG-SGA nutrition assessment data obtained in the present
study, the majority of participants identified themselves as having low to moderate
nutritional concerns. In fact, two-thirds (67.7%) were considered to be wellnourished while the remaining participants (32.3%) were identified as experiencing
some degree of nutritional compromise. Therefore, the prevalence of nutrition
related issues found in the present study is slightly lower than numbers reported in
past studies of individuals with HNCa (Baldwin & Weekes, 2011; Isenring, Bauer &
Capra, 2003). This in part may be explained by considering the demographics of our
study population. Specifically, the present study assessed individuals who were being
treated on an outpatient basis, many of who were approximately a year post-
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treatment. Further, many participants in the current cohort received surgery as their
sole treatment modality. These factors all contribute to lower nutrition-related
concerns. For example, outpatients would be expected to have lower nutritional
compromise than those individuals who require hospital admittance as their cancerrelated circumstances are likely less severe (Ravera, Bozzetti, Ammatuna, & Radaelli,
1987; Stratton et al., 2004). Additionally, nutrition impact symptoms are expected to
decline with time post-treatment as recovery time increases (Isenring et al., 2007).
Finally, surgical treatments tend to be associated with a lesser degree of nutritional
compromise than other treatment modalities as its effects tend to be more shortterm (Van Cutsem & Arends, 2005). These trends may offer a possible explanation for
the lower rate of nutritional compromise reported in the present investigation.
However, despite lower rates than expected, nutritional concerns were still
found to exist in 32.3% of our population. Knowing the broad impact that
compromised nutrition status can have on an individual’s treatment outcome and
recovery, the finding that one-third of current participants were nutritionally
challenged is concerning. This emphasizes the need to consider the nutritional
concerns of outpatients both during and following HNCa treatment. It also should be
noted that despite the observation of a relatively lower percentage of nutritionally
compromised individuals when compared to past reports (Gupta et al., 2011; Shaw et
al., 2014; Takenaka et al., 2014), certain individuals did still experience and reported
significant nutritional problems. Scores gathered from the PG-SGA assessment
ranged from 1 – 17 from a possible range of 0 - 50 (M = 5.6) which suggests that
following diagnosis and treatment for HNCa, an individual’s nutrition status can vary
greatly; further, one’s status can be influenced by a variety of factors, the most
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common of which was identified by the present study as being “Dry Mouth”, this
agrees with past literature (Larsson et al., 2005). Though not all individuals will
experience nutritional concerns, it would be irresponsible from a healthcare
perspective to disregard those who are experiencing such problems as they may be
hindering recovery and functioning (van Leeuwen et al., 1997). Though nutrition
assessments have inherent limitations which may prevent routine implementation, it
is possible that self-administered nutrition screening tools may overcome these
limitations (Cawood et al., 2012). The finding that one third of study participants
presented with nutrition related concerns justifies exploration into the ability of
nutrition screening tools to be self-administered in an accurate and reliable manner
by individuals of the outpatient HNCa population.
Patient Generated – Subjective Global Assessment Short Form (PG-SGA SF)
Though literature exploring the application of the PG-SGA SF is relatively
small, there has been a focus on the oncology population. From these studies, the
PG-SGA SF has proven to be a reliable tool for assessing the nutrition status of
oncology outpatients with fair-to-good sensitivity and specificity (Abbott et al., 2016;
Gabrielson et al., 2013). As this tool has proven reliable for a broad cancer
population, explorations into its applicability in oncology populations where
nutritional concerns tend to be more severe is warranted, such as in the HNCa
population. This was assessed through examination of the sensitivity, specificity, and
positive and negative predictive values of the PG-SGA SF. Scores obtained on the PGSGA SF ranged from 0 - 15 (M = 3.85) from a possible range of 0 - 36, results that are
comparable to those of the PG-SGA. The most commonly reported symptom on the
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PG-SGA SF was “dry mouth”, a finding that is in agreement with the PG-SGA. Overall,
the PG-SGA SF identified almost 27% of participants as being nutritionally
compromised, a similar rate to that of the PG-SGA. This rate is lower than other
prevelance rates reported in literature of between 35-80% (Gupta et al., 2011; Lees,
1999; Takenaka et al., 2014) however, recent studies have reported similar rates
using the PG-SGA SF (Jager-Wittenaar & Ottery, 2017). The resultant sensitivity and
specificity were 81.8% and 100%, respectively, and the positive and negatively
predictive values were 100% and 92%, respectively, this again is in agreement with
past literature (Jager-Wittenaar & Ottery, 2017). Thus, all values reached or
exceeded cut-off points of above 80% for the PG-SGA SF (Azad, et al., 1999).
Additionally, averaging 1.82 minutes to complete, the PG-SGA SF was able to be
quickly self-completed by participants.
It must be noted, however, that sensitivity, specificity, and negative and
positive predictive values were expected to be high as the PG-SGA SF is based on the
original PG-SGA (the PG-SGA SF is identical to the first four boxes of the PG-SGA
assessment). Ideally, we would hope that any nutritional screen would be able to
accurately identify malnutrition when present, while at the same time not requiring
additional evaluation for those not experiencing nutritional deficits. As seen
throughout this study, however, there were occasions where additional scoring (i.e.,
the professionally completed portion of the PG-SGA) resulted in several individuals
being identified as nutritionally compromised. Thus, the increased efficiency of the
PG-SGA SF came at a small expense to its accuracy relative to the PG-SGA
assessment. However, as previously stated, all values assessing accuracy and
reliability of the PG-SGA SF reached acceptable levels in the present study (Isenring,
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Banks, Ferguson, & Bauer, 2012). This warrants further investigation into the use of
the PG-SGA SF as a self-administered nutrition screening tool. Doing so could provide
the much needed first step in the nutrition care pathway for these outpatients with
HNCa. Further, results obtained may provide an efficient and proactive means of
identifying HNCa outpatients at nutritional risk. Once risk is identified, those
individuals can then receive comprehensive nutritional assessments to further
identify problems and potentially lead to intervention.
Pt-Global Application
The Pt-Global Application was designed by Dr. Faith Ottery and her team in an
attempt to streamline and increase the efficiency of the nutrition screening process
(Ottery et al., 2015). Like the PG-SGA SF, the Pt-Global Application is also based on
the original PG-SGA. The Pt-Global Application is identical to the PG-SGA except that
it is in an automated format. This enables the Pt-Global Application to be utilized as
either a nutrition screening tool (if only patient reported sections are completed) or a
nutrition assessment tool (both patient and professional reported sections are
completed). Thus, if utilized for screening purposes, it has the potential to be entirely
self-completed by patients. The Pt-Global application may increase the efficiency of
the nutrition screening process by reducing the time required to complete an
accurate nutrition screen as all calculations and output scores are completed by the
automated tool. This increased level of efficiency could make the Pt-Global
application a practical first step in the nutrition care pathway for outpatients with
HNCa. However, at present there is no information on the utility of the Pt-Global
Application as a screening tool within the HNCa population. Therefore, one of the
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aims of the present investigation was to assess whether the Pt-Global Application
could be used as a nutrition screening tool on an outpatient basis for those being
treated for HNCa. This was completed by examining the sensitivity and specificity, as
well as positive and negative predictive values of the Pt-Global Application.
Pt-Global Application scores obtained ranged from 0 - 13 (M = 3.35) from a
possible range of 0 - 36, which are slightly lower than the PG-SGA assessment scores.
The most commonly reported nutrition impact symptoms reported on the Pt-Global
Application were, “dry mouth” and “lack of appetite”. The finding that “dry mouth”
was the most commonly reported nutrition impact symptom agreed with results
obtained by the PG-SGA as well as with past literature (Larsson et al., 2005).
However, it was reported by fewer individuals on the Pt-Global Application than on
either of the PG-SGA SF or PG-SGA. This inconsistency between the Pt-Global
Application and both the PG-SGA SF and PG-SGA may illustrate the potential for
misreporting when this automated tool is used. Overall, 20.6% of participants were
identified using the Pt-Global Application as being nutritionally compromised. This is
slightly lower than the rate reported for the PG-SGA SF, which only differs by mode
of delivery, and lower than rates reported in the literature (Gupta et al., 2011; JagerWittenaar & Ottery, 2017; Lees, 1999; Takenaka et al., 2014). Additionally, the PtGlobal Application took slightly longer to complete, averaging 3.71 minutes. These
findings might be partially explained by examining the results obtained from the
ease-of-use survey. Our participants reported either no preference between the two
screening tools, or preferred the paper-based PG-SGA SF nutrition screen. Those who
preferred the paper-based PG-SGA SF may have been uncomfortable or
inexperienced with using automated tools such as the Pt-Global Application. Despite
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this, sensitivity and specificity values of 63.6% and 100%, respectively, were achieved
by the Pt-Global Application as well as a positive and negative predictive values of
100% and 85.2%, respectively. Again, these ratings were expected to be high given
that the Pt-Global Application is based on the original PG-SGA. However, like the PGSGA SF, the Pt-Global Application was also not as precise as the PG-SGA assessment
and was unable to replicate its results with 100% accuracy.
The lower scores and decreased accuracy of the Pt-Global Application can
have consequences for the treatment of those individuals who were nutritionally
borderline regarding their category rating of A, B, or C, or their triaging
recommendations output by the tool. The results they received from the Pt-Global
Application may not have been as serious/urgent as those provided by the more
thorough PG-SGA assessment. That being noted, the Pt-Global Application still
managed to achieve acceptable levels of specificity and negative and positive
predictive values. These psychometric properties are similar to those reported for
other nutrition screening tools (Jager-Wittenaar & Ottery, 2017; Skipper et al., 2012).
It is, however, critical to seek a clinical screen that holds the greatest likelihood of
identifying nutritional problems when they in fact are present, yet also reduces the
likelihood of misidentification. These findings are believed to warrant its potential for
use, or at the very least, further investigation into its applicability as a selfadministered nutrition screening tool for individuals of the HNCa population being
treated on an outpatient basis.
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Ease-of-Use Survey
The concluding segments the ease-of-use survey included open-ended
questions where participants could provide additional information. The two final
questions of the ease-of-use survey addressed any comments/concerns participants
had regarding each nutrition screening tool used within the present study. Of the 34
participants, seven provided additional comments which provided an opportunity to
better our understanding of the participant’s experience with each of the tools.
The majority of participant comments pertained to the difficulty of using the
Pt-Global Application without professional assistance. Individuals who are unfamiliar
using technology and mobile/computer applications may feel uncomfortable using
the Pt-Global Application. This could potentially lead to misreporting of the
information required by the Pt-Global nutrition screen, which then could result in
errors in the final nutrition scores and triaging recommendations. This concern was
consistent with the data collected within the present investigation. Mean scores for
all ease-of-use survey questions were higher for the PG-SGA SF when compared to
the corresponding questions for the Pt-Global Application. This indicates that
participants were in higher agreement for the statements when they referred to the
PG-SGA SF. This suggests that participants felt that the PG-SGA SF paper-based
nutrition screening form was easier to use.
It is not surprising that a generation which is unfamiliar and less comfortable
with these types of electronic applications might experience difficulties attempting to
utilize them in clinical and research settings. As time progresses and the generations
which grew up using these applications age and begin forming the HNCa population
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it is possible that the Pt-Global Application may gain favour over a paper-based
format. However, efforts that assess differences in screening tool preference
between younger and older demographic groups is needed to determine whether
this assumption is valid.
Results of the EORTC QLQ-C30
The responses provided by study participants to questions of the EORTC
indicated that the experience of an individual being treated on an outpatient basis
for HNCa can vary greatly. Though some individuals did not report experiencing any
symptoms, the majority reported experiencing at least a few of the concerns
addressed by the EORTC QLQ-C30. Some participants (n = 21) experienced no or
minimal impact to their QOL (a sum score of 42 or less on the first 28 questions of
the QLQ-C30), while six experienced a moderate-to-large impact on QOL (a sum score
of 56 or greater). The most commonly reported items were Question 10 “Did you
need rest?”, Question 18 “Were you tired?”, and Question 22 “Did you worry?” with
22, 25, and 22, participants, respectively, noting concerns. This also was a common
concern of individuals with HNCa reported in a study by Capra et al. (2001). However,
for symptoms reported to be experienced “Very much” within the present
investigation, there was wide variation. Participants reported a symptom as “Very
much” a concern 34 times, with 19 different items on the QLQ-C30 being selected at
least once. The individualized nature of how nutritional status in influenced over the
course of HNCa therapy has been outlined in various other studies utilizing
hospitalized patients (Arends et al., 2016; Capra et al., 2001; Larsson et al., 2005).
This variability also being present in outpatient makes it difficult to identify which
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areas one should target to improve the QOL of this population. The best approach
seems to be to individualize therapies to identify and address those factors having
the greatest negative influence on QOL.
What became apparent once nutrition status was brought into consideration
was that the majority of symptoms reported as “Very much” a concern had been
reported by nutritionally compromised individuals (28 of the 34). Furthermore,
whenever a significant difference was observed between the means of reported
items it was the nutritionally compromised group which presented with the greater
QOL concern. A similar trend was observed when participants rated their personal
health and Global QOL status. The nutritionally compromised individuals continued
to indicate lower mean scores for these domains. This suggests that a correlation
existed between nutrition status and a worse perceived personal health and Global
QOL status in the present investigation, a finding that agrees with past reports
(Silander, Nyman & Hammerlid, 2013). However, as this is a correlational assessment
it is difficult to determine if nutrition status is what is causing lower perceptions of
health and Global QOL, or vice versa. Further research is needed in order to
investigate the direction of this correlation.
Another interesting finding was that a similar pattern became apparent when
the participant functional domain scores were observed. That is, for every functional
domain assessed by the QLQ-C30, the mean scores of the nutritionally compromised
group were lower, with the “Physical”, “Social”, and “Cognitive” domains all reaching
significance. The finding that functionality is increasingly impaired with declining
nutrition status agrees with past studies (Farhangfar et al., 2014; Kubrak et al., 2013).
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Overall, when comparing perceived personal “functional status” in the present
investigation, those comprising the nutritionally compromised group judged their
functioning to be worse. This pattern held true for all the symptom domains as well,
with one exception (diarrhea) which was not significant. The nutritionally
compromised individuals indicated that they were experiencing these symptoms to a
higher degree with “fatigue”, “appetite loss”, and “constipation” reaching
significance. This finding that greater symptom burden was associated with greater
nutritional concerns also agrees with past literature (Capuano et al., 2010; Farhangfar
et al., 2014; List et al., 1997; Reeve et al., 2016). The cumulative effects of a greater
symptom burden and lower perceived functional status may offer a partial
explanation for the lower Global QOL domain scores reported by the nutritionally
compromised individuals in the present study. Overall, the data suggest that
nutrition status of HNCa outpatients is associated with their functionality, symptom
burden, and perceived health and Global QOL. This illustrates the importance of
nutrition care practices such as screening.
Results of the EORTC QLQ-H&N35
The EORTC QLQ-H&N35 module was designed specifically for individuals with
HNCa. As was the case with the EORTC QLQ-C30, though the majority of participants
reported experiencing a subset of the symptoms, individual experiences varied. Some
participants (n = 19) experienced none or minimal impact to their QOL (determined
by a sum score of 52 or less), while a few others (n = 7) experienced a moderate-tolarge impact on QOL (a score of >70). The most commonly reported symptoms on the
H&N35 were Question 15 “Have you coughed?” and Question 11 “Did you have a
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dry mouth?” (n= 21 and 20, respectively). Additionally, the symptom which was most
commonly reported as “Very much” a concern was Question 7 “Have you had trouble
swallowing solid food?” (n=5). The high prevalence of dry mouth and swallowing
problems reported in the present cohort agrees with past literature on others with
HNCa (Chasen & Bhargava, 2009; Larsson et al., 2005). These observations highlight
the need for the implementation of routine nutrition screening practices as it is clear
that these nutrition symptoms are present in those treated for HNCa. Furthermore,
various differences were once again observed between the mean scores of individual
items reported by the nutritionally compromised and well-nourished groups. In every
instance a significant difference was observed it was the nutritionally compromised
who had reported the greater QOL concern. This suggests that those who were
nutritionally compromised at the time of the study also reported greater QOL
impacts based on the QLQ-H&N35, a finding supported by past literature (Silander et
al., 2013). Thus, efforts which aim to address the nutrition related concerns of
individuals with HNCa through nutrition screening could identify and address these
issues which may result in appreciable benefits for health and QOL.
EORTC QLQ-H&N35 domain scores produced similar results to those of the
QLQ-C30 in regards to the differences between the well-nourished and nutritionally
compromised groups. The nutritionally compromised group reported greater QOL
concerns for all symptom domains with exception of “Pain”, “Nutritional
supplementation” and “Weight gain” none of which reached significance. To explain
these findings, it could be assumed that nutritional supplements would help
individuals remain well-nourished and thus retain, or possibly even gain, weight.
Despite debate, the benefit of nutritional supplementation, has positively influenced
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weight retention in individuals with cancer (Baldwin & Weekes, 2012). Additionally,
the experience of pain was possibly a greater concern for the well-nourished group
because the use of pain-killers was much more common among the nutritionally
compromised group. Domains reaching significance included “senses” and “speech
problems”, “teeth”, and “dry mouth”. These significant findings for our outpatient
cohort agree with past findings regarding the common concerns of hospitalized
patients with HNCa (Alshadwi et al., 2013; Chasen & Bhargava, 2009; Hayward &
Shea, 2009; Larsson et al., 2005). Overall, for the majority of these QOL symptoms,
the nutritionally compromised group perceived that they were experiencing them to
a greater extent. This again warrants efforts targeting the nutritional concerns of
outpatients treated for HNCa as doing so could mitigate their effects and result in
QOL improvements.
In summary, data obtained from the QLQ-C30 and H&N35 demonstrate that a
significant variability exists among individuals with HNCa in regard to their
perception of nutrition status, functionality and QOL. Possibly the most important
finding for the present study was the differences identified between the wellnourished and nutritionally compromised groups. These results suggest that there is
an association between the incidence of a poor nutrition status and the experience
of a worse functionality and QOL for outpatients with HNCa.
Consistency of Responses
The present data illustrate a correlation between participant’s responses for
the QOL, nutrition measures, and functional and symptom domain scores. When
individuals reported a lower perceived QOL, they also tended to present with poorer

89

nutrition scores and worse functional and symptom domain scores. This suggests
that those participants who were experiencing greater nutrition related concerns
also tended to experience a greater symptom burden, worse functionality and a
lower perceived health and Global QOL status.
Correlational Analysis
The domains selected for the correlational analysis were those which were
thought to, or have proven in the past to, retain a potential to influence nutrition
status (Farhangfar et al., 2014; Kubrak et al., 2010). This resulted in the inclusion of
Global QOL scores, the five functional domain scores, and 12 of the 27 “symptom”
domain scores from each of the EORTC QLQ-C30 and H&N35 in addition to the
nutrition scores recorded by the PG-SGA nutrition assessment. This correlational
analysis revealed a number of moderate positive and negative relationships which
are remarkable. First, a moderate inverse relationship was found between the Global
QOL domain and the nutrition scores obtained from the PG-SGA nutrition
assessment. This suggests that with higher nutrition related concerns QOL decreases
(Silander et al., 2013). This illustrates that, at least in part, QOL is influenced
negatively by a declining nutritional status.
Next, moderate relationships were also discovered to exist among the PGSGA nutrition scores, Global QOL and the physical, cognitive and social functioning
domain scores. The presence of these relationships suggests that as nutritional status
worsens, functional ability may decline (Farhangfar et al., 2014; Kubrak et al., 2013).
This is a logical conclusion given that a declining nutrition status may decrease one’s
social functioning as they no longer desire to eat with friends and family (Penner,
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2009). Worse nutrition status also has the potential to result in increased tiredness
which can negatively influence physical and cognitive functioning (Capuano et al.,
2010; Ma et al., 2013). Conversely, the reverse could also be true and a reduced
functional status could be resulting in a declining nutrition status. Despite the
precipitating factor being difficult to identify, it is evident that many interrelated
factors are influencing the nutrition status, functionality, and Global QOL of
individuals with HNCa.
Next, when evaluating the correlations present between the PG-SGA
assessment scores and the individual symptom scores of the EORTC QLQ-C30 and
H&N35 various moderate associations were identified. The symptoms identified as
being most strongly correlated with PG-SGA scores were “Senses problems”, r(32)
=0.6, p<0.01, “Appetite loss”, r(32) = 0.58, p<0.01, and “Constipation”, r(32) = 0.56,
p<0.01. These three symptom domains also had moderate-to-strong correlations
with Global QOL and subsets of the functional domains. This suggest that as
individuals experience these symptoms to a higher degree, it becomes more likely
that their nutritional status will decline along with their perception of their Global
QOL and functionality (). These findings are not unexpected, individuals with cancer
commonly experience these types of symptoms which can influence QOL (Capuano
et al., 2010; Farhangfar et al., 2014; Gorenc et al., 2015; List et al., 1997; McQuestion,
2006; Reeve et al., 2016). Efforts attempting to identify and address these types of
short- and long-term nutritional concerns could result in improvements for nutrition
status, functionality, and the perceived health and QOL of individuals with HNCa.
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Supplemental Observational Analysis
Multiple relationships present within this investigation may offer useful
insights into how the nutrition status of outpatient individuals with HNCa may be
influenced. However, it must be noted that the experiences of individuals within the
present study varied significantly. Thus, supplemental analyses of the data were
completed in order to consider further influences on participant nutrition status.
First a visual examination of potential trends related to treatment modality
were considered. As HNCa can occur at a variety of different sites and stages, the
treatment options also vary. T-tests were performed to assess the data across the
different treatment modality categories which suggested that individuals who had
received surgery alone retained a better nutrition status (t(33)=2.75, p<0.01), as well
as a better Global QOL (t(33)=3.95, p<0.001). An assessment of time-post treatment
revealed no significant relationships with treatment type, nutrition, or QOL scores, a
finding which diverges from past studies (Tong et al., 2009). Thus, time-post
treatment did not provide an explanation for these observed trends in the present
study, suggesting that treatment modality influenced both nutrition status and QOL.
This is not an unexpected finding as it has been reported in past studies that surgery
tends to have less severe impacts on nutrition than alternative treatment modalities
(Arends et al., 2016; Van Cutsem & Arends, 2005).
Next, the influence of smoking status on nutrition status was explored as
tobacco consumption is known to influence appetite (Alshadwi et al., 2013).
Statistical analysis revealed the mean nutrition scores of non-smokers and the
combined group of current and past smokers differed significantly (t(33)=2.58,
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p<0.05). Non-smokers presented with lower nutritional concerns, a finding which
agrees with past literature (Haghjoo, 2015). It was interesting however, that former
smokers presented with higher nutrition scores than current tobacco users. This
finding is possibly related to the former smoker’s tendency to have longer histories of
tobacco use which may result in greater, long-lasting, nutritional compromise.
Finally, the influence of age on nutrition status was examined as nutritionrelated concerns tend to become more common as one ages (Stratton & Elia, 2005).
Data in the present investigation supported this, illustrating that nutritional concerns
increased with age, r(32)=0.48, p<0.01. However, the correlation between age and
QOL scores was insignificant. This suggests that despite increasing nutrition-related
complications with age, individual participants were not necessarily perceiving
corresponding declines in their QOL with age. Thus, perceived QOL may not be a
strong indication of nutritional concerns. This justifies the implementation of routine
nutrition screening in order to identify and proactively manage the nutritional
concerns of individuals with HNCa, mitigating their negative effects.
Summary
The results of this preliminary study suggest that PG-SGA SF and Pt-Global
Application can serve as self-administered nutrition screens. Both instruments could
potentially be utilized as effective first steps in the nutrition care pathway for
outpatients with HNCa. Thus, both tools deserve to be investigated further regarding
their ability to be administered on a routine basis in healthcare settings. Currently,
the PG-SGA SF is preferred over the Pt-Global Application by the outpatient HNCa
population. This however, could change as comfort levels utilizing electronic
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applications increase. The findings from the present investigation also illustrated that
nutrition status is indeed influenced by HNCa and its treatment on an individualized
basis. These impacts on nutrition status can have significant corresponding impacts
on individual Global QOL. Further, a worse nutrition status was found to be
associated with a lower perceived functional ability, as well as an increased symptom
burden. Finally, the data also suggest that nutrition status may be influenced by
factors such as treatment modality, smoking status, and age. These findings illustrate
the importance of nutrition care practices from a QOL perspective and provide
justification for the implementation of routine nutrition screening in the outpatient
HNCa population.
Clinical implications
The frequent failure to recognize and treat malnutrition in populations where
it is a common concern, such as for those with HNCa, has been stated as being
unacceptable (Elia et al., 2005). Early identification of malnutrition in those treated
for HNCa would enable early intervention and present a tremendous opportunity to
reduce weight loss, healthcare costs, treatment complications, hospital readmissions,
mortality and morbidity rates, improve performance status, clinical outcomes, overall
care and QOL (Capuano et al., 2010; Isenring et al., 2004; Tappenden et al., 2013).
However, for these benefits to become a reality, nutrition status must be regularly
assessed and the appropriate interventions must be provided. Proactive approaches
to nutrition management tend to be more successful than approaches delayed until
later stages of excessive weight loss (Baldwin & Weekes, 2012; Isenring et al., 2007;
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Langius et al., 2016; Ravasco et al., 2008;). Until nutritional evaluations become
routine, proactive solutions addressing nutritional concerns will likely remain evasive.
In the present study the PG-SGA SF achieved acceptable levels of accuracy
and reliability, supporting its potential to be used as a nutrition screening tool in the
HNCa outpatient population. The Pt-Global Application did achieve acceptable levels
of specificity, however, more work must be done to improve the sensitivity of the
tool or comfort levels using electronic applications must increase if this nutrition
screening tool is to be used effectively. If these changes occur, the Pt-Global
Application could potentially streamline the nutrition screening process.
Thus, either of the current PG-SGA SF or an improved version of the Pt-Global
Application, if proven reliable, could be implemented in clinical practice.
Implementation of these nutrition screens may enable the efficient and accurate
identification of those at nutritional risk who may require further comprehensive
nutrition assessments. Similarly, findings from such screening may also serve to
reduce unnecessary referrals. This would yield many benefits such as increased
efficiency, timely access to information, safety, improved healthcare as well as
significantly reduce healthcare expenses (David et al., 2013). Additionally, as the PGSGA SF and Pt-Global Application can be utilized as self-administered measurements,
they overcome many challenges and limitations associated with current screening
tools such as limited time and financial resources (Abbott et al., 2014; Santarpia et
al., 2011).
Overall, the findings of the present study indicate that self-administered
nutrition screens are viable options for addressing the nutrition related concerns of
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HNCa outpatients. Thus, the use of screening to identify nutrition concerns appears
justified and investigations into the implementation of efficient screening tools has
been suggested (Cawood et al., 2012; Kondrup et al., 2003). As nutrition concerns are
common and costly side-effects of HNCa treatment which take significant time to
address, screening and addressing them proactively could reduce costs spent
addressing them at later stages of treatment (Abizanda et al., 2016; Baracos, 2006;
Prevost et al., 2014). Thus, nutrition screening may yield benefits for individual
health and QOL as well as the healthcare system.
Limitations of Present Study
Certain limitations exist relative to the present study. The first is sample size.
Given the relatively limited number of participants, casual conclusions cannot be
made regarding the changes to nutrition status following a diagnosis and treatment
for HNCa. Additionally, only a single recruitment site was utilized in the present
study, a surgical clinic. Thus, results cannot be generalized to participants diagnosed
and treated at different locations as the patient population, the type of treatment
services and the quality of those provided services may differ at a separate location.
Also, as participants in this study performed self-assessments on both the nutrition
screens and the QOL instruments, it is possible that participant bias was present in
how they perceived and reported their health, QOL and nutrition status. Recall bias is
always a concern when participants are asked to report on past behaviours. Finally,
data were only collected from participants who were between three months postdiagnosis to two years post-treatment. Thus, it is possible that the data does not
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capture the full experience of individuals with HNCa given the variability of treatment
side-effects and potential longer-term issues.
The demographic variability of the study population presents a further
limitation. Participants varied across demographic variables and various subgroups of
patients existed, each characterized by their own unique variability. Such variability
prevents generalized claims from being made due to the mediating or moderating
factors accompanying each of these unique circumstances. This limitation could be
addressed by increasing the number of participants and identifying homogenous subgroups. The increased homogeneity would enable more accurate assessments of
factors influencing the nutrition status of outpatient individuals with HNCa by
minimizing the effects of mediating and moderating factors. Determining how these
factors influence the nutrition of individuals with HNCa may provide insights for
future investigations on self-administered nutrition screens.
Directions for Future Research
Though the absence of a universal definition for malnutrition in the HNCa
population from which nutrition evaluations and interventions can be based remains
an issue, this should not discourage future efforts that seek to address nutritional
concerns (Cushen et al., 2015). This study provided a strong justification for the
routine use of nutrition screening tools in the healthcare system. It has provided a
starting point for research that seeks to assess how instruments such as the PG-SGA
SF and Pt-Global Application might be used over the course of the diagnosis,
treatment, and follow-up. Though, the topic of nutrition status in oncology is gaining
increasing recognition, limited information exists on the use self-administered

97

nutrition screens in the area of HNCa and the majority of work currently completed
focuses on hospitalized individuals. Continued research into how these types of
instruments might be used in clinical settings is important (Cawood et al., 2012;
Kondrup et al., 2003). The efficient implementation of such tools could help mitigate
the consequences associated with the treatment of HNCa, decrease post-treatment
complications, optimize rehabilitation efforts, and reduce the workloads of
healthcare professionals (Cawood et al., 2012; David et al., 2013).
Future research might assess the impact of altering threshold scores of the
self-administered nutrition screens used in this study in order increase their accuracy
ratings. Additional research might also be performed assessing the ability of the PtGlobal Application as a self-administered nutrition screen to be completed over the
internet as this tool is application based. Examinations into the compliance of
individuals to complete the Pt-Global Application online and the reliability of these
screens could therefore be targeted in future studies.
Though it is unlikely that the nutritional concerns associated with HNCa
treatment can be completely eliminated, understanding which factors have the
greatest influence on nutrition status and how an impaired nutrition status
influences functionality may provide valuable information moving forward. This
information may guide targeted therapies for nutritional concerns, resulting in
reductions in healthcare expenses as well as QOL and health status improvements.
Overall, the primary goal of continuing research into self-administered
nutrition screening tools in the HNCa population is to find an instrument which
achieves acceptable rates of sensitivity and specificity in order to justify its routine
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implementation. Such a tool would enable proactive identification of nutritional
concerns while also transferring the responsibility of completing these screens from
busy healthcare professionals to the individual (Cawood et al., 2012; David et al.,
2013).
Conclusions
Though treatments for individuals diagnosed with cancers continue to
improve, these individuals still face an array of treatment-related consequences.
Decreases in functional abilities and QOL are among some of the most common
outcomes associated with cancer treatments (Ma et al., 2013; Sherman et al., 2000).
Treatment for HNCa is no exception. Though treatment methods vary due to the
heterogeneity of this cancer, they often retain the potential to have psychosocial and
physical impacts on the individuals being treated (Penner, 2009). These impacts can
result in a diminishing nutrition status for individuals diagnosed and treated for HNCa
and this was supported by the findings of this initial study. The data collected suggest
that compromised nutrition status remains a common concern for those treated for
HNCa. Further, the findings of the present study agree with past literature that
nutrition status can be influenced by many variables such as treatment modality (Van
Cutsem & Arends, 2005), smoking status (Hall et al., 2000; Reeve et al., 2016), and
age (Stratton & Elia, 2005).
The findings of the present investigation suggest that nutrition screening
could help to proactively identify nutritional concerns of outpatients with HNCa. As
healthcare professionals are already experiencing heavy workloads, measurements
which can effectively and reliably be utilized for self-screening are desirable and have

99

been called for (Cawood et al., 2012). The findings from this study support this
method of self-screening nutrition status as a viable option with paper-based
screening tools currently being the preferred mode of delivery. Given that diminished
nutrition status is associated with an array of negative implications for treatment
outcomes and the rehabilitation process, the use of self-administered nutrition
screening tools, such as the PG-SGA SF and the Pt-Global Application may provide a
cost-effective solution. Such instruments would proactively identify nutrition-related
concerns while also lessening the burden experienced by healthcare professionals.
This could yield benefits for the health and QOL of HNCa outpatients (Capuano et al.,
2010; Isenring et al., 2004; Tappenden et al., 2013). Thus, continued efforts exploring
these crucial concepts are warranted due to the potential for both short- and longterm improvements in patient care, treatment outcomes, and QOL.
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APPENDIX B

Laboratory for Well-Being and Quality of life in Oncology University of Western Ontario
Letter of Information
Principal Investigators: Philip C. Doyle, Ph.D., Mark J.P. Lynch, M.Sc., Julie A. Theurer, Ph.D.
Project Title: “The application of self-administered nutrition screening tools and evaluations
of the impact of malnutrition on quality of life in individuals with head and neck cancer”
Purpose of the study
The purpose of this letter is to provide you with information required for you to make an
informed decision regarding participation in this research. This study will examine the ability
of up to 100 individuals with head and neck cancer to self-screen their nutrition status, as
well as how nutrition status relates to quality of life in this population. This study will identify
if individuals with head and neck cancer have an ability to reliably self-screen nutrition
status; this may give this group a more direct and active role in their treatment and help
professionals understand their nutrition status. Parts of this study represent a Master’s
thesis project for one of the investigators (ML).
Activities of participants
If you agree to participate, you will complete a general demographic information survey
(e.g., age, gender, etc.). You will then complete two nutrition status self-screens (PG-SGA SF
& Pt-Global App) as well as an ease-of-use questionnaire. During this visit, you will also
complete two quality of life questionnaires (EORTC-QLQ-C30 & EORTC-QLQ-HN35).
Information gathered from each survey and questionnaire will be coded so that your identity
remains confidential. Following this you will then undergo a brief non-invasive physician
administered examination for the PG-SGA nutrition assessment. The remaining information
for completion of the nutrition assessment shall be gathered by the researcher from patient
charts. The entire procedure (questionnaire completion, nutrition screen and nutrition
assessment) will take place in a quiet clinic room at the London Health Sciences Centre and
should take less than 20 minutes.
Exclusion Criteria
You will be excluded from participating in the study if you are younger than 30 or older than
80 years of age. Individuals with skin cancers shall be excluded as these types of cancers
should not increase the risk of nutritional decline. Participants unable to read or speak
English will be excluded as these individuals would struggle to complete the tasks necessary
for this study. For similar reasons participants with severe physical disabilities, dementia or
other obvious cognitive impairments, or if their vision does not permit them to see the
questionnaires shall also be excluded.
Possible risks involved
There are no known risks or discomforts associated with participation in this research study.
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Participation is voluntary. You may refuse to participate, refuse to answer any questions or
perform any part nutrition screens or nutrition assessment, or withdraw from the study at
any time. You do not waive any legal rights by signing the consent form. Finally, withdrawal
from the study will in no way influence your continuing medical care. There is no discomfort
with either the nutrition screens or nutrition assessment.
Possible benefits involved
Due to the nature of this study, you will not directly benefit from the data obtained and you
will not be compensated for your participation in this research. We would, however, be happy
to share the results of our findings with you should you desire.
Voluntary Participation
Participation in this study is voluntary and you may refuse to participate, refuse to answer
any questions or withdraw from the study at any time. Doing so will have no effect on your
current or future medical care. By signing the consent form to participate within this study
you do not waive any legal rights.
Confidentiality
All data collected will remain confidential to the best of our ability. Your data will be
identified by a code known only to the investigators. If the results are published, your name
will not be used. If you choose to withdraw from this study, your data will be removed and
destroyed from our database. It is also a possibility that qualified representatives from
Lawson Quality Assurance Education Program and University of Western Ontario Health
Sciences Research Ethics Board may look at participants’ records for quality assurance.

Contacts for further questions
If you require any further information regarding this research project or your participation in
the study, please feel free to contact:
Philip Doyle, Ph.D. or Mark J.P. Lynch, M.Sc.
Laboratory for Well-Being and Quality of Life in Oncology, Rehabilitation Sciences Elborn
College, University of Western Ontario, London, Ontario N6G 1H1
519-661-2111 ext. 88942 pdoyle@uwo.ca
mlynch47@uwo.ca
If you have any questions about your rights as a research participant or the conduct of this
study, you may contact:
David Hill, FCAHS
Lawson Health Research Institute Director and Integrated Vice President, Research for
London Health Sciences Centre and St. Joseph’s Health Care London
519-646-6100 ext. 64716
Western University, The Office of Human Research Ethics
Room 5150 Support Services Building, 1393 Western Road, London, Ontario, Canada,
N6G1G9 Tel: RDS: 519-661-2161 | Research Ethics: 519-661-3036
ethics@uwo.ca
This letter is for you to keep.
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APPENDIX C
Demographic Information Survey
Title: “The application of self-administered nutrition screening tools and evaluations of the
impact of malnutrition on quality of life in individuals with head and neck cancer”
Study Investigators: Philip Doyle, Ph.D., Mark Lynch, B.H.Sc., M.Sc. (Candidate), Julie
Theurer, Ph.D.
Please read the following questions carefully and provide answers as accurately as possible.
For multiple choice options, please circle all choices that apply to you. If no suitable options
exist, please use the space provided to explain. Also, if there is any additional information
that you feel is important to report regarding your body image or perceived QOL, please use
the back of these pages to include it.
Sex: M / F / Other
Age: ____________ Year of Birth: ___________
Month of Birth: ___________ Number of months since your diagnosis: _____________
What is your current treatment status?
a) Currently waiting for treatment
b) Currently undergoing treatment
c) Completed treatment
Site of Cancer:
a) Oral cavity (e.g., lip, tongue, cheek, tonsil, etc.)
b) Larynx (voice box)
c) Throat (e.g., pharynx, hypopharynx, oropharynx)
d) Thyroid
e) Sinuses/Paranasal sinuses
f) Other
If “other”, please specify:
____________________________________________________________________

Method of Treatment:
a) Surgery
b) Radiation therapy
c) Chemotherapy
d) Chemoradiation therapy
e) Other
If “other”, please specify:
____________________________________________________________________
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Marital Status (circle one):
a) Married
b) Separated
c) Divorced
d) Widowed
e) Common-law
f) Engaged
g) Single
h) Other
If “other”, please specify:
____________________________________________________________________
Occupational Status:
a) Currently working – full-time
b) Currently working – part-time
c) Volunteer
d) Retired
e) Other
If “other”, please specify:
____________________________________________________________________
Highest Level of Education Achieved:
a) Less than high school
b) Some high school
c) Completed High school
d) Some college/post secondary
e) Completed college/post-secondary
f) Apprenticeship
g) Trade school
c) Undergraduate University degree (i.e., Bachelor’s degree)
d) Post-graduate University degree (i.e., Master’s degree, Doctorate)
e) Other
If “other”, please specify:
____________________________________________________________________
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Tobaccos use status:
a) Currently use tobacco products
b) Formerly used tobacco products
c) Never used tobacco products
If you currently use, or used tobacco products, approximately what quantity of what product
(e.g., cigarettes, chewing tobacco, cigars, etc.) do/did you consume in an average week?
_______________________________________________________________________
Alcohol use status:
a) Currently consume alcohol
b) Formerly consumed alcohol
c) Never consumed alcohol
If you currently consume, or used to consume alcohol, approximately how many beverages
do/did you consume in an average week? _______________________________________

Household income (optional):
a) Less than $25,000
b) $25,000 - $50,000
c) $50,001 - $ 75,000
d) Greater than $75,000
e) Would prefer not to say

Please feel free to include any additional information that you feel is important specific to
this project in the space provided below or on the opposite side of this document. Thank
you.
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
________________________________________________
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APPENDIX D

EORTC QLQ-C30 (version 3)
We are interested in some things about you and your health. Please answer all of the questions yourself
by circling the number that best applies to you. There are no "right" or "wrong" answers. The information
that you provide will remain strictly confidential.
Please fill in your initials:
Your birthdate (Day, Month, Year):
Today's date (Day, Month, Year):
Not at
All

A
Little

Quite
a Bit

Very
Much

1. Do you have any trouble doing strenuous activities,
like carrying a heavy shopping bag or a suitcase?

1

2

3

4

2. Do you have any trouble taking a long walk?

1

2

3

4

3. Do you have any trouble taking a short walk outside of the house? 1

2

3

4

4. Do you need to stay in bed or a chair during the day?

1

2

3

4

5. Do you need help with eating, dressing, washing
yourself or using the toilet?

1

2

3

4

During the past week:
6. Were you limited in doing either your work or other daily
activities?
7. Were you limited in pursuing your hobbies or other leisure
time activities?

Not at A Little Quite a Very
All
Bit Much
1
2
3
4

8. Were you short of breath?

1
1

2
2

3
3

4
4

9. Have you had pain?

1

2

3

4

10. Did you need to rest?

1

2

3

4

11. Have you had trouble sleeping?

1

2

3

4

12. Have you felt weak?

1

2

3

4

13. Have you lacked appetite?

1

2

3

4

14. Have you felt nauseated?

1

2

3

4

15. Have you vomited?

1

2

3

4

16. Have you been constipated?

1

2

3

4

Please go on to the next page
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During the past week:

Not at
All

A
Little

Quite
a Bit

Very
Much

17. Have you had diarrhea?

1

2

3

4

18. Were you tired?

1

2

3

4

19. Did pain interfere with your daily activities?

1

2

3

4

20. Have you had difficulty in concentrating on things, like
reading a newspaper or watching television?

1

2

3

4

21. Did you feel tense?

1

2

3

4

22. Did you worry?

1

2

3

4

23. Did you feel irritable?

1

2

3

4

24. Did you feel depressed?

1

2

3

4

25. Have you had difficulty remembering things?

1

2

3

4

26. Has your physical condition or medical treatment
interfered with your family life?

1

2

3

4

27. Has your physical condition or medical treatment
interfered with your social activities?

1

2

3

4

28. Has your physical condition or medical treatment
caused you financial difficulties?

1

2

3

4

For the following questions please circle the number between 1 and 7 that best applies
to you
29. How would you rate your overall health during the past week?
1

2

3

4

5

6

7

Very poor

Excellent

30. How would you rate your overall quality of life during the past week?
1

2

3

4

5

6

Very poor

7
Excellent

© Copyright 1995 EORTC Quality of Life Group. All rights reserved. Version 3.0
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APPENDIX E

EORTC QLQ - H&N35

Patients sometimes report that they have the following symptoms or problems. Please indicate
the extent to which you have experienced these symptoms or problems during the past week.
Please answer by circling the number that best applies to you.
During the past week:

Not at all

31. Have you had pain in your mouth?

1

2

3

4

32. Have you had pain in your jaw?

1

2

3

4

33. Have you had soreness in your mouth?

1

2

3

4

34. Have you had a painful throat?

1

2

3

4

35. Have you had problems swallowing liquids?

1

2

3

4

36. Have you had problems swallowing pureed food? 1

2

3

4

37. Have you had problems swallowing solid food?

1

2

3

4

38. Have you choked when swallowing?

1

2

3

4

39. Have you had problems with your teeth?

1

2

3

4

40. Have you had problems opening your mouth
wide?
41. Have you had a dry mouth?

1

2

3

4

1

2

3

4

42. Have you had sticky saliva?

1

2

3

4

43. Have you had problems with your sense of smell? 1

2

3

4

44. Have you had problems with your sense of taste? 1

2

3

4

45. Have you coughed?

1

2

3

4

46. Have you been hoarse?

1

2

3

4

47. Have you felt ill?

1

2

3

4

48. Has your appearance bothered you?

1

2

3

4

Please go on to the next page
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A Quite a Very
little bit much

During the past week:

Not at
all

A
Quite Very
little a bit much

49. Have you had trouble eating?

1

2

3

4

50. Have you had trouble eating in front of your family?

1

2

3

4

51. Have you had trouble eating in front of other people?

1

2

3

4

52. Have you had trouble enjoying your meals?

1

2

3

4

53. Have you had trouble talking to other people?

1

2

3

4

54. Have you had trouble talking on the telephone?

1

2

3

4

55. Have you had trouble having social contact with your
family?
56. Have you had trouble having social contact with friends?

1

2

3

4

1

2

3

4

57. Have you had trouble going out in public?

1

2

3

4

58. Have you had trouble having physical contact with family
or friends?

1

2

3

4

59. Have you felt less interest in sex?

1

2

3

4

60. Have you felt less sexual enjoyment?

1

2

3

4

During the past week:

No

61. Have you used pain-killers?

Yes

1
62. Have you taken any nutritional supplements (excluding vitamins)? 1

2
2

63. Have you used a feeding tube?

1

2

64. Have you lost weight?

1

2

65. Have you gained weight?

1

2

© Copyright 1994 EORTC Quality of Life Study Group, version 1.0 All rights reserved
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APPENDIX H
Ease of use form
Initials:
Age:
Gender:
For each item identified below, circle the number to the right of each question that best
describes your level of agreement with the statement.
Survey Item

Strongly
Disagree

Disagree

Undecided

Agree

Strongly
Agree

1.

The PG-SGA SF is easy to use.

1

2

3

4

5

2.

The PG-SGA SF is organized in a way
that is easy to understand.

1

2

3

4

5

3.

The items and questions asked on the
PG-SGA SF were simple and easy to
understand.

1

2

3

4

5

The PG-SGA SF can be completed
quickly and easily without the aid of a
professional.

1

2

3

4

5

5.

The PG-SGA SF was a simple tool for
assessing my own nutrition status.

1

2

3

4

5

6.

The Pt-Global App is easy to use.

1

2

3

4

5

7.

The Pt-Global App is organized in a way
that is easy to understand.

1

2

3

4

5

8.

The items and questions asked on the
Pt-Global App were simple and easy to
understand.

1

2

3

4

5

The Pt-Global App can be completed
quickly and easily without the aid of a
professional.

1

2

3

4

5

10.

The Pt-Global App was a simple tool for
assessing my own nutrition status.

1

2

3

4

5

11.

If you experienced any difficulties using
the PG-SGA SF please list them to the
right along with any suggestions for
improvement.

12.

If you experienced any difficulties using
the Pt-Global App please list them to
the right along with any suggestions for
improvement.

4.

9.
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